Reunió 20/10/2020
Lípid de referencia: PI 34:1
Resultats PI 34:1 Sa High vs Sa Low
Cluster Sample
Determinació Beta
Cluster gens
Correlació mòduls i fenotips
Gens drivers dels mòduls associats al fenotip
GO
Es mostren els 10 millors GO
| X | module | size | p.val | Bonf | nInTerm | GO.id | ont | term.name |
|---|---|---|---|---|---|---|---|---|
| 1 | antiquewhite4 | 47 | 6.4e-04 | 1.000 | 3 | GO:0016765 | MF | transferase activity, transferring alkyl or aryl (other than methyl) groups |
| 2 | antiquewhite4 | 47 | 1.2e-03 | 1.000 | 2 | GO:0032331 | BP | negative regulation of chondrocyte differentiation |
| 3 | antiquewhite4 | 47 | 2.1e-03 | 1.000 | 2 | GO:1903203 | BP | regulation of oxidative stress-induced neuron death |
| 4 | antiquewhite4 | 47 | 2.3e-03 | 1.000 | 2 | GO:0061037 | BP | negative regulation of cartilage development |
| 5 | antiquewhite4 | 47 | 2.7e-03 | 1.000 | 2 | GO:0035666 | BP | TRIF-dependent toll-like receptor signaling pathway |
| 6 | antiquewhite4 | 47 | 2.7e-03 | 1.000 | 2 | GO:0036475 | BP | neuron death in response to oxidative stress |
| 7 | antiquewhite4 | 47 | 3.3e-03 | 1.000 | 1 | GO:0006193 | BP | ITP catabolic process |
| 8 | antiquewhite4 | 47 | 3.3e-03 | 1.000 | 1 | GO:0009104 | BP | lipopolysaccharide catabolic process |
| 9 | antiquewhite4 | 47 | 3.3e-03 | 1.000 | 1 | GO:0034150 | BP | toll-like receptor 6 signaling pathway |
| 10 | antiquewhite4 | 47 | 3.3e-03 | 1.000 | 1 | GO:0035921 | BP | desmosome disassembly |
| 11 | bisque4 | 63 | 1.4e-03 | 1.000 | 3 | GO:0005518 | MF | collagen binding |
| 12 | bisque4 | 63 | 2.3e-03 | 1.000 | 2 | GO:0050750 | MF | low-density lipoprotein particle receptor binding |
| 13 | bisque4 | 63 | 3.5e-03 | 1.000 | 2 | GO:0070325 | MF | lipoprotein particle receptor binding |
| 14 | bisque4 | 63 | 4.1e-03 | 1.000 | 12 | GO:0005102 | MF | signaling receptor binding |
| 15 | bisque4 | 63 | 4.2e-03 | 1.000 | 1 | GO:0002364 | BP | NK T cell lineage commitment |
| 16 | bisque4 | 63 | 4.2e-03 | 1.000 | 1 | GO:0002489 | BP | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent |
| 17 | bisque4 | 63 | 4.2e-03 | 1.000 | 1 | GO:0015805 | BP | S-adenosyl-L-methionine transport |
| 18 | bisque4 | 63 | 4.2e-03 | 1.000 | 1 | GO:1901962 | BP | S-adenosyl-L-methionine transmembrane transport |
| 19 | bisque4 | 63 | 4.2e-03 | 1.000 | 1 | GO:1904027 | BP | negative regulation of collagen fibril organization |
| 20 | bisque4 | 63 | 4.2e-03 | 1.000 | 1 | GO:0099065 | CC | integral component of spine apparatus membrane |
| 21 | black | 461 | 2.7e-04 | 1.000 | 3 | GO:1901896 | BP | positive regulation of ATPase-coupled calcium transmembrane transporter activity |
| 22 | black | 461 | 9.3e-04 | 1.000 | 2 | GO:1902963 | BP | negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
| 23 | black | 461 | 1.0e-03 | 1.000 | 15 | GO:0032869 | BP | cellular response to insulin stimulus |
| 24 | black | 461 | 1.1e-03 | 1.000 | 6 | GO:0032731 | BP | positive regulation of interleukin-1 beta production |
| 25 | black | 461 | 1.2e-03 | 1.000 | 5 | GO:0031369 | MF | translation initiation factor binding |
| 26 | black | 461 | 1.5e-03 | 1.000 | 24 | GO:0009991 | BP | response to extracellular stimulus |
| 27 | black | 461 | 1.8e-03 | 1.000 | 12 | GO:0051170 | BP | import into nucleus |
| 28 | black | 461 | 2.1e-03 | 1.000 | 3 | GO:1901894 | BP | regulation of ATPase-coupled calcium transmembrane transporter activity |
| 29 | black | 461 | 2.1e-03 | 1.000 | 3 | GO:0008190 | MF | eukaryotic initiation factor 4E binding |
| 30 | black | 461 | 2.2e-03 | 1.000 | 18 | GO:0071375 | BP | cellular response to peptide hormone stimulus |
| 31 | blue | 1795 | 1.5e-04 | 1.000 | 7 | GO:0008417 | MF | fucosyltransferase activity |
| 32 | blue | 1795 | 3.1e-04 | 1.000 | 26 | GO:0007156 | BP | homophilic cell adhesion via plasma membrane adhesion molecules |
| 33 | blue | 1795 | 9.7e-04 | 1.000 | 5 | GO:0051351 | BP | positive regulation of ligase activity |
| 34 | blue | 1795 | 1.3e-03 | 1.000 | 10 | GO:0086091 | BP | regulation of heart rate by cardiac conduction |
| 35 | blue | 1795 | 1.4e-03 | 1.000 | 7 | GO:0036065 | BP | fucosylation |
| 36 | blue | 1795 | 1.4e-03 | 1.000 | 20 | GO:0034451 | CC | centriolar satellite |
| 37 | blue | 1795 | 1.7e-03 | 1.000 | 3 | GO:0016560 | BP | protein import into peroxisome matrix, docking |
| 38 | blue | 1795 | 1.7e-03 | 1.000 | 3 | GO:0090427 | BP | activation of meiosis |
| 39 | blue | 1795 | 1.7e-03 | 1.000 | 3 | GO:0000818 | CC | nuclear MIS12/MIND complex |
| 40 | blue | 1795 | 1.7e-03 | 1.000 | 3 | GO:0002081 | CC | outer acrosomal membrane |
| 41 | blue2 | 34 | 6.3e-04 | 1.000 | 2 | GO:0071782 | CC | endoplasmic reticulum tubular network |
| 42 | blue2 | 34 | 9.7e-04 | 1.000 | 2 | GO:0045907 | BP | positive regulation of vasoconstriction |
| 43 | blue2 | 34 | 2.2e-03 | 1.000 | 1 | GO:0015904 | BP | tetracycline transmembrane transport |
| 44 | blue2 | 34 | 2.2e-03 | 1.000 | 1 | GO:0038193 | BP | thromboxane A2 signaling pathway |
| 45 | blue2 | 34 | 2.2e-03 | 1.000 | 1 | GO:0030849 | CC | autosome |
| 46 | blue2 | 34 | 2.2e-03 | 1.000 | 1 | GO:0004597 | MF | peptide-aspartate beta-dioxygenase activity |
| 47 | blue2 | 34 | 2.2e-03 | 1.000 | 1 | GO:0004961 | MF | thromboxane A2 receptor activity |
| 48 | blue2 | 34 | 2.2e-03 | 1.000 | 1 | GO:0005166 | MF | neurotrophin p75 receptor binding |
| 49 | blue2 | 34 | 2.2e-03 | 1.000 | 1 | GO:0008493 | MF | tetracycline transmembrane transporter activity |
| 50 | blue2 | 34 | 2.2e-03 | 1.000 | 1 | GO:0047464 | MF | heparosan-N-sulfate-glucuronate 5-epimerase activity |
| 51 | brown | 724 | 1.1e-04 | 1.000 | 3 | GO:0001534 | CC | radial spoke |
| 52 | brown | 724 | 6.6e-04 | 1.000 | 50 | GO:0050801 | BP | ion homeostasis |
| 53 | brown | 724 | 7.8e-04 | 1.000 | 41 | GO:0055065 | BP | metal ion homeostasis |
| 54 | brown | 724 | 8.3e-04 | 1.000 | 7 | GO:0061462 | BP | protein localization to lysosome |
| 55 | brown | 724 | 9.2e-04 | 1.000 | 60 | GO:0022857 | MF | transmembrane transporter activity |
| 56 | brown | 724 | 9.4e-04 | 1.000 | 51 | GO:0015075 | MF | ion transmembrane transporter activity |
| 57 | brown | 724 | 1.1e-03 | 1.000 | 45 | GO:0055080 | BP | cation homeostasis |
| 58 | brown | 724 | 1.1e-03 | 1.000 | 84 | GO:0055085 | BP | transmembrane transport |
| 59 | brown | 724 | 1.3e-03 | 1.000 | 4 | GO:0007501 | BP | mesodermal cell fate specification |
| 60 | brown | 724 | 1.4e-03 | 1.000 | 7 | GO:0097028 | BP | dendritic cell differentiation |
| 61 | brown2 | 34 | 3.7e-04 | 1.000 | 2 | GO:0032933 | BP | SREBP signaling pathway |
| 62 | brown2 | 34 | 4.3e-04 | 1.000 | 2 | GO:0071501 | BP | cellular response to sterol depletion |
| 63 | brown2 | 34 | 4.6e-04 | 1.000 | 7 | GO:1990234 | CC | transferase complex |
| 64 | brown2 | 34 | 4.9e-04 | 1.000 | 2 | GO:0006991 | BP | response to sterol depletion |
| 65 | brown2 | 34 | 5.1e-04 | 1.000 | 4 | GO:0046890 | BP | regulation of lipid biosynthetic process |
| 66 | brown2 | 34 | 6.2e-04 | 1.000 | 9 | GO:1902494 | CC | catalytic complex |
| 67 | brown2 | 34 | 6.7e-04 | 1.000 | 4 | GO:0007623 | BP | circadian rhythm |
| 68 | brown2 | 34 | 7.2e-04 | 1.000 | 3 | GO:0050810 | BP | regulation of steroid biosynthetic process |
| 69 | brown2 | 34 | 8.8e-04 | 1.000 | 2 | GO:0010894 | BP | negative regulation of steroid biosynthetic process |
| 70 | brown2 | 34 | 9.7e-04 | 1.000 | 2 | GO:0045939 | BP | negative regulation of steroid metabolic process |
| 71 | brown4 | 67 | 6.3e-05 | 1.000 | 2 | GO:1902109 | BP | negative regulation of mitochondrial membrane permeability involved in apoptotic process |
| 72 | brown4 | 67 | 3.1e-04 | 1.000 | 2 | GO:0035795 | BP | negative regulation of mitochondrial membrane permeability |
| 73 | brown4 | 67 | 4.4e-04 | 1.000 | 2 | GO:0051103 | BP | DNA ligation involved in DNA repair |
| 74 | brown4 | 67 | 4.4e-04 | 1.000 | 2 | GO:1905709 | BP | negative regulation of membrane permeability |
| 75 | brown4 | 67 | 7.5e-04 | 1.000 | 2 | GO:0000014 | MF | single-stranded DNA endodeoxyribonuclease activity |
| 76 | brown4 | 67 | 1.0e-03 | 1.000 | 8 | GO:0006875 | BP | cellular metal ion homeostasis |
| 77 | brown4 | 67 | 1.1e-03 | 1.000 | 2 | GO:0032754 | BP | positive regulation of interleukin-5 production |
| 78 | brown4 | 67 | 1.1e-03 | 1.000 | 2 | GO:0051561 | BP | positive regulation of mitochondrial calcium ion concentration |
| 79 | brown4 | 67 | 1.2e-03 | 1.000 | 4 | GO:0008637 | BP | apoptotic mitochondrial changes |
| 80 | brown4 | 67 | 1.5e-03 | 1.000 | 5 | GO:0006839 | BP | mitochondrial transport |
| 81 | coral | 30 | 1.7e-04 | 1.000 | 3 | GO:0042273 | BP | ribosomal large subunit biogenesis |
| 82 | coral | 30 | 2.3e-04 | 1.000 | 2 | GO:0046415 | BP | urate metabolic process |
| 83 | coral | 30 | 6.2e-04 | 1.000 | 4 | GO:0015291 | MF | secondary active transmembrane transporter activity |
| 84 | coral | 30 | 7.5e-04 | 1.000 | 4 | GO:0008514 | MF | organic anion transmembrane transporter activity |
| 85 | coral | 30 | 8.5e-04 | 1.000 | 2 | GO:0030687 | CC | preribosome, large subunit precursor |
| 86 | coral | 30 | 9.4e-04 | 1.000 | 2 | GO:0000470 | BP | maturation of LSU-rRNA |
| 87 | coral | 30 | 2.1e-03 | 1.000 | 1 | GO:0021919 | BP | BMP signaling pathway involved in spinal cord dorsal/ventral patterning |
| 88 | coral | 30 | 2.1e-03 | 1.000 | 1 | GO:1903712 | BP | cysteine transmembrane transport |
| 89 | coral | 30 | 2.1e-03 | 1.000 | 1 | GO:1904677 | BP | positive regulation of somatic stem cell division |
| 90 | coral | 30 | 2.1e-03 | 1.000 | 1 | GO:2000103 | BP | positive regulation of mammary stem cell proliferation |
| 91 | coral1 | 46 | 9.7e-05 | 1.000 | 3 | GO:0033120 | BP | positive regulation of RNA splicing |
| 92 | coral1 | 46 | 1.2e-03 | 1.000 | 2 | GO:0048026 | BP | positive regulation of mRNA splicing, via spliceosome |
| 93 | coral1 | 46 | 1.4e-03 | 1.000 | 4 | GO:0000819 | BP | sister chromatid segregation |
| 94 | coral1 | 46 | 1.8e-03 | 1.000 | 2 | GO:0015949 | BP | nucleobase-containing small molecule interconversion |
| 95 | coral1 | 46 | 2.9e-03 | 1.000 | 1 | GO:0060566 | BP | positive regulation of DNA-templated transcription, termination |
| 96 | coral1 | 46 | 2.9e-03 | 1.000 | 1 | GO:1903569 | BP | positive regulation of protein localization to ciliary membrane |
| 97 | coral1 | 46 | 2.9e-03 | 1.000 | 1 | GO:2000806 | BP | positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled |
| 98 | coral1 | 46 | 2.9e-03 | 1.000 | 1 | GO:0035632 | CC | mitochondrial prohibitin complex |
| 99 | coral1 | 46 | 2.9e-03 | 1.000 | 1 | GO:0001850 | MF | complement component C3a binding |
| 100 | coral1 | 46 | 2.9e-03 | 1.000 | 1 | GO:1902118 | MF | calcidiol binding |
| 101 | coral2 | 48 | 2.4e-03 | 1.000 | 2 | GO:0034698 | BP | response to gonadotropin |
| 102 | coral2 | 48 | 2.8e-03 | 1.000 | 8 | GO:0005730 | CC | nucleolus |
| 103 | coral2 | 48 | 2.8e-03 | 1.000 | 2 | GO:0018146 | BP | keratan sulfate biosynthetic process |
| 104 | coral2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0070981 | BP | L-asparagine biosynthetic process |
| 105 | coral2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0008456 | MF | alpha-N-acetylgalactosaminidase activity |
| 106 | coral2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0030110 | MF | HLA-C specific inhibitory MHC class I receptor activity |
| 107 | coral2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0033735 | MF | aspartate dehydrogenase activity |
| 108 | coral2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0046525 | MF | xylosylprotein 4-beta-galactosyltransferase activity |
| 109 | coral2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0070037 | MF | rRNA (pseudouridine) methyltransferase activity |
| 110 | coral2 | 48 | 3.6e-03 | 1.000 | 2 | GO:0042339 | BP | keratan sulfate metabolic process |
| 111 | cyan | 215 | 9.4e-05 | 1.000 | 11 | GO:0030246 | MF | carbohydrate binding |
| 112 | cyan | 215 | 2.0e-04 | 1.000 | 2 | GO:2000502 | BP | negative regulation of natural killer cell chemotaxis |
| 113 | cyan | 215 | 5.9e-04 | 1.000 | 2 | GO:1901624 | BP | negative regulation of lymphocyte chemotaxis |
| 114 | cyan | 215 | 1.4e-03 | 1.000 | 3 | GO:0005092 | MF | GDP-dissociation inhibitor activity |
| 115 | cyan | 215 | 1.6e-03 | 1.000 | 3 | GO:0050145 | MF | nucleoside monophosphate kinase activity |
| 116 | cyan | 215 | 1.9e-03 | 1.000 | 2 | GO:1990430 | MF | extracellular matrix protein binding |
| 117 | cyan | 215 | 3.1e-03 | 1.000 | 3 | GO:1901623 | BP | regulation of lymphocyte chemotaxis |
| 118 | cyan | 215 | 3.5e-03 | 1.000 | 3 | GO:0000272 | BP | polysaccharide catabolic process |
| 119 | cyan | 215 | 4.0e-03 | 1.000 | 2 | GO:0051660 | BP | establishment of centrosome localization |
| 120 | cyan | 215 | 4.0e-03 | 1.000 | 2 | GO:0051902 | BP | negative regulation of mitochondrial depolarization |
| 121 | darkgreen | 153 | 1.0e-04 | 1.000 | 2 | GO:2000225 | BP | negative regulation of testosterone biosynthetic process |
| 122 | darkgreen | 153 | 3.0e-04 | 1.000 | 2 | GO:0072125 | BP | negative regulation of glomerular mesangial cell proliferation |
| 123 | darkgreen | 153 | 3.0e-04 | 1.000 | 2 | GO:0090194 | BP | negative regulation of glomerulus development |
| 124 | darkgreen | 153 | 3.0e-04 | 1.000 | 2 | GO:2000224 | BP | regulation of testosterone biosynthetic process |
| 125 | darkgreen | 153 | 3.4e-04 | 1.000 | 3 | GO:0072075 | BP | metanephric mesenchyme development |
| 126 | darkgreen | 153 | 6.0e-04 | 1.000 | 2 | GO:0030620 | MF | U2 snRNA binding |
| 127 | darkgreen | 153 | 9.9e-04 | 1.000 | 2 | GO:0061370 | BP | testosterone biosynthetic process |
| 128 | darkgreen | 153 | 9.9e-04 | 1.000 | 2 | GO:1901723 | BP | negative regulation of cell proliferation involved in kidney development |
| 129 | darkgreen | 153 | 1.2e-03 | 1.000 | 3 | GO:0060444 | BP | branching involved in mammary gland duct morphogenesis |
| 130 | darkgreen | 153 | 1.5e-03 | 1.000 | 3 | GO:0043153 | BP | entrainment of circadian clock by photoperiod |
| 131 | darkgrey | 142 | 2.1e-04 | 1.000 | 6 | GO:0030660 | CC | Golgi-associated vesicle membrane |
| 132 | darkgrey | 142 | 3.6e-04 | 1.000 | 3 | GO:0098962 | BP | regulation of postsynaptic neurotransmitter receptor activity |
| 133 | darkgrey | 142 | 4.4e-04 | 1.000 | 3 | GO:0060749 | BP | mammary gland alveolus development |
| 134 | darkgrey | 142 | 4.4e-04 | 1.000 | 3 | GO:0061377 | BP | mammary gland lobule development |
| 135 | darkgrey | 142 | 6.2e-04 | 1.000 | 6 | GO:0016798 | MF | hydrolase activity, acting on glycosyl bonds |
| 136 | darkgrey | 142 | 7.9e-04 | 1.000 | 5 | GO:0004553 | MF | hydrolase activity, hydrolyzing O-glycosyl compounds |
| 137 | darkgrey | 142 | 8.6e-04 | 1.000 | 3 | GO:0030137 | CC | COPI-coated vesicle |
| 138 | darkgrey | 142 | 1.0e-03 | 1.000 | 8 | GO:0045211 | CC | postsynaptic membrane |
| 139 | darkgrey | 142 | 1.2e-03 | 1.000 | 4 | GO:0002011 | BP | morphogenesis of an epithelial sheet |
| 140 | darkgrey | 142 | 1.3e-03 | 1.000 | 2 | GO:0060534 | BP | trachea cartilage development |
| 141 | darkmagenta | 81 | 8.6e-05 | 1.000 | 2 | GO:0035494 | BP | SNARE complex disassembly |
| 142 | darkmagenta | 81 | 1.9e-04 | 1.000 | 3 | GO:0000729 | BP | DNA double-strand break processing |
| 143 | darkmagenta | 81 | 4.3e-04 | 1.000 | 2 | GO:0021814 | BP | cell motility involved in cerebral cortex radial glia guided migration |
| 144 | darkmagenta | 81 | 5.9e-04 | 1.000 | 2 | GO:0008627 | BP | intrinsic apoptotic signaling pathway in response to osmotic stress |
| 145 | darkmagenta | 81 | 5.9e-04 | 1.000 | 2 | GO:0046833 | BP | positive regulation of RNA export from nucleus |
| 146 | darkmagenta | 81 | 6.7e-04 | 1.000 | 3 | GO:1903672 | BP | positive regulation of sprouting angiogenesis |
| 147 | darkmagenta | 81 | 9.1e-04 | 1.000 | 4 | GO:0043535 | BP | regulation of blood vessel endothelial cell migration |
| 148 | darkmagenta | 81 | 9.2e-04 | 1.000 | 5 | GO:0045766 | BP | positive regulation of angiogenesis |
| 149 | darkmagenta | 81 | 1.3e-03 | 1.000 | 2 | GO:0008253 | MF | 5’-nucleotidase activity |
| 150 | darkmagenta | 81 | 1.5e-03 | 1.000 | 3 | GO:0048260 | BP | positive regulation of receptor-mediated endocytosis |
| 151 | darkolivegreen | 83 | 8.8e-05 | 1.000 | 2 | GO:0070292 | BP | N-acylphosphatidylethanolamine metabolic process |
| 152 | darkolivegreen | 83 | 1.3e-03 | 1.000 | 2 | GO:1990459 | MF | transferrin receptor binding |
| 153 | darkolivegreen | 83 | 1.6e-03 | 1.000 | 2 | GO:0030897 | CC | HOPS complex |
| 154 | darkolivegreen | 83 | 1.6e-03 | 1.000 | 2 | GO:0031543 | MF | peptidyl-proline dioxygenase activity |
| 155 | darkolivegreen | 83 | 2.0e-03 | 1.000 | 3 | GO:0008333 | BP | endosome to lysosome transport |
| 156 | darkolivegreen | 83 | 3.0e-03 | 1.000 | 2 | GO:0019511 | BP | peptidyl-proline hydroxylation |
| 157 | darkolivegreen | 83 | 4.2e-03 | 1.000 | 7 | GO:0048568 | BP | embryonic organ development |
| 158 | darkolivegreen | 83 | 4.9e-03 | 1.000 | 29 | GO:0046872 | MF | metal ion binding |
| 159 | darkolivegreen | 83 | 5.3e-03 | 1.000 | 2 | GO:0031418 | MF | L-ascorbic acid binding |
| 160 | darkolivegreen | 83 | 5.5e-03 | 1.000 | 1 | GO:0000105 | BP | histidine biosynthetic process |
| 161 | darkolivegreen4 | 41 | 2.1e-05 | 0.390 | 2 | GO:0008109 | MF | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity |
| 162 | darkolivegreen4 | 41 | 6.0e-04 | 1.000 | 5 | GO:0019898 | CC | extrinsic component of membrane |
| 163 | darkolivegreen4 | 41 | 2.1e-03 | 1.000 | 5 | GO:0009100 | BP | glycoprotein metabolic process |
| 164 | darkolivegreen4 | 41 | 2.5e-03 | 1.000 | 3 | GO:0031109 | BP | microtubule polymerization or depolymerization |
| 165 | darkolivegreen4 | 41 | 2.7e-03 | 1.000 | 1 | GO:0047412 | MF | N-(long-chain-acyl)ethanolamine deacylase activity |
| 166 | darkolivegreen4 | 41 | 5.4e-03 | 1.000 | 1 | GO:0002121 | BP | inter-male aggressive behavior |
| 167 | darkolivegreen4 | 41 | 5.4e-03 | 1.000 | 1 | GO:0016557 | BP | peroxisome membrane biogenesis |
| 168 | darkolivegreen4 | 41 | 5.4e-03 | 1.000 | 1 | GO:0044861 | BP | protein transport into plasma membrane raft |
| 169 | darkolivegreen4 | 41 | 5.4e-03 | 1.000 | 1 | GO:1903244 | BP | positive regulation of cardiac muscle hypertrophy in response to stress |
| 170 | darkolivegreen4 | 41 | 5.4e-03 | 1.000 | 1 | GO:0042721 | CC | TIM22 mitochondrial import inner membrane insertion complex |
| 171 | darkorange | 106 | 9.4e-06 | 0.170 | 6 | GO:0061640 | BP | cytoskeleton-dependent cytokinesis |
| 172 | darkorange | 106 | 2.6e-05 | 0.480 | 3 | GO:1904896 | BP | ESCRT complex disassembly |
| 173 | darkorange | 106 | 2.6e-05 | 0.480 | 3 | GO:1904903 | BP | ESCRT III complex disassembly |
| 174 | darkorange | 106 | 6.3e-05 | 1.000 | 5 | GO:0000281 | BP | mitotic cytokinesis |
| 175 | darkorange | 106 | 6.3e-05 | 1.000 | 5 | GO:0043130 | MF | ubiquitin binding |
| 176 | darkorange | 106 | 6.7e-05 | 1.000 | 4 | GO:0060236 | BP | regulation of mitotic spindle organization |
| 177 | darkorange | 106 | 9.9e-05 | 1.000 | 5 | GO:0051303 | BP | establishment of chromosome localization |
| 178 | darkorange | 106 | 1.1e-04 | 1.000 | 3 | GO:0061952 | BP | midbody abscission |
| 179 | darkorange | 106 | 1.6e-04 | 1.000 | 7 | GO:0070507 | BP | regulation of microtubule cytoskeleton organization |
| 180 | darkorange | 106 | 1.7e-04 | 1.000 | 3 | GO:1901673 | BP | regulation of mitotic spindle assembly |
| 181 | darkorange2 | 68 | 4.4e-04 | 1.000 | 2 | GO:0007442 | BP | hindgut morphogenesis |
| 182 | darkorange2 | 68 | 5.8e-04 | 1.000 | 2 | GO:0061525 | BP | hindgut development |
| 183 | darkorange2 | 68 | 8.3e-04 | 1.000 | 3 | GO:0000307 | CC | cyclin-dependent protein kinase holoenzyme complex |
| 184 | darkorange2 | 68 | 9.6e-04 | 1.000 | 3 | GO:0032623 | BP | interleukin-2 production |
| 185 | darkorange2 | 68 | 9.6e-04 | 1.000 | 3 | GO:0043277 | BP | apoptotic cell clearance |
| 186 | darkorange2 | 68 | 1.1e-03 | 1.000 | 2 | GO:0020027 | BP | hemoglobin metabolic process |
| 187 | darkorange2 | 68 | 1.4e-03 | 1.000 | 2 | GO:0010820 | BP | positive regulation of T cell chemotaxis |
| 188 | darkorange2 | 68 | 1.4e-03 | 1.000 | 2 | GO:0019908 | CC | nuclear cyclin-dependent protein kinase holoenzyme complex |
| 189 | darkorange2 | 68 | 1.6e-03 | 1.000 | 2 | GO:0010819 | BP | regulation of T cell chemotaxis |
| 190 | darkorange2 | 68 | 1.6e-03 | 1.000 | 2 | GO:0032511 | BP | late endosome to vacuole transport via multivesicular body sorting pathway |
| 191 | darkred | 148 | 1.9e-04 | 1.000 | 3 | GO:0050965 | BP | detection of temperature stimulus involved in sensory perception of pain |
| 192 | darkred | 148 | 2.5e-04 | 1.000 | 4 | GO:0030331 | MF | estrogen receptor binding |
| 193 | darkred | 148 | 6.7e-04 | 1.000 | 3 | GO:0050951 | BP | sensory perception of temperature stimulus |
| 194 | darkred | 148 | 7.9e-04 | 1.000 | 3 | GO:0016048 | BP | detection of temperature stimulus |
| 195 | darkred | 148 | 1.4e-03 | 1.000 | 2 | GO:0016272 | CC | prefoldin complex |
| 196 | darkred | 148 | 2.5e-03 | 1.000 | 2 | GO:0004706 | MF | JUN kinase kinase kinase activity |
| 197 | darkred | 148 | 3.3e-03 | 1.000 | 2 | GO:1900116 | BP | extracellular negative regulation of signal transduction |
| 198 | darkred | 148 | 3.5e-03 | 1.000 | 4 | GO:0035258 | MF | steroid hormone receptor binding |
| 199 | darkred | 148 | 3.9e-03 | 1.000 | 14 | GO:0009986 | CC | cell surface |
| 200 | darkred | 148 | 4.0e-03 | 1.000 | 2 | GO:0007256 | BP | activation of JNKK activity |
| 201 | darkseagreen3 | 28 | 9.4e-05 | 1.000 | 2 | GO:2000643 | BP | positive regulation of early endosome to late endosome transport |
| 202 | darkseagreen3 | 28 | 1.8e-04 | 1.000 | 2 | GO:0032536 | BP | regulation of cell projection size |
| 203 | darkseagreen3 | 28 | 3.5e-04 | 1.000 | 2 | GO:2000641 | BP | regulation of early endosome to late endosome transport |
| 204 | darkseagreen3 | 28 | 1.4e-03 | 1.000 | 2 | GO:0045022 | BP | early endosome to late endosome transport |
| 205 | darkseagreen3 | 28 | 1.9e-03 | 1.000 | 1 | GO:0035238 | BP | vitamin A biosynthetic process |
| 206 | darkseagreen3 | 28 | 1.9e-03 | 1.000 | 1 | GO:0097323 | BP | B cell adhesion |
| 207 | darkseagreen3 | 28 | 1.9e-03 | 1.000 | 1 | GO:1901810 | BP | beta-carotene metabolic process |
| 208 | darkseagreen3 | 28 | 3.7e-03 | 1.000 | 1 | GO:0016116 | BP | carotenoid metabolic process |
| 209 | darkseagreen3 | 28 | 3.7e-03 | 1.000 | 1 | GO:0016119 | BP | carotene metabolic process |
| 210 | darkseagreen3 | 28 | 3.7e-03 | 1.000 | 1 | GO:0016121 | BP | carotene catabolic process |
| 211 | darkseagreen4 | 46 | 4.2e-04 | 1.000 | 2 | GO:0050872 | BP | white fat cell differentiation |
| 212 | darkseagreen4 | 46 | 8.4e-04 | 1.000 | 2 | GO:0006004 | BP | fucose metabolic process |
| 213 | darkseagreen4 | 46 | 1.0e-03 | 1.000 | 5 | GO:0030667 | CC | secretory granule membrane |
| 214 | darkseagreen4 | 46 | 1.6e-03 | 1.000 | 2 | GO:0097602 | MF | cullin family protein binding |
| 215 | darkseagreen4 | 46 | 1.7e-03 | 1.000 | 2 | GO:0002021 | BP | response to dietary excess |
| 216 | darkseagreen4 | 46 | 1.8e-03 | 1.000 | 3 | GO:0035579 | CC | specific granule membrane |
| 217 | darkseagreen4 | 46 | 2.1e-03 | 1.000 | 2 | GO:0007214 | BP | gamma-aminobutyric acid signaling pathway |
| 218 | darkseagreen4 | 46 | 3.1e-03 | 1.000 | 1 | GO:0015854 | BP | guanine transport |
| 219 | darkseagreen4 | 46 | 3.1e-03 | 1.000 | 1 | GO:0035344 | BP | hypoxanthine transport |
| 220 | darkseagreen4 | 46 | 3.1e-03 | 1.000 | 1 | GO:0035364 | BP | thymine transport |
| 221 | darkslateblue | 63 | 1.8e-05 | 0.330 | 4 | GO:0085029 | BP | extracellular matrix assembly |
| 222 | darkslateblue | 63 | 6.0e-04 | 1.000 | 3 | GO:0014009 | BP | glial cell proliferation |
| 223 | darkslateblue | 63 | 7.5e-04 | 1.000 | 2 | GO:0005797 | CC | Golgi medial cisterna |
| 224 | darkslateblue | 63 | 9.1e-04 | 1.000 | 2 | GO:0043256 | CC | laminin complex |
| 225 | darkslateblue | 63 | 1.3e-03 | 1.000 | 2 | GO:0060253 | BP | negative regulation of glial cell proliferation |
| 226 | darkslateblue | 63 | 1.5e-03 | 1.000 | 2 | GO:0070831 | BP | basement membrane assembly |
| 227 | darkslateblue | 63 | 1.5e-03 | 1.000 | 4 | GO:0001889 | BP | liver development |
| 228 | darkslateblue | 63 | 2.5e-03 | 1.000 | 2 | GO:0002320 | BP | lymphoid progenitor cell differentiation |
| 229 | darkslateblue | 63 | 2.5e-03 | 1.000 | 2 | GO:0140058 | BP | neuron projection arborization |
| 230 | darkslateblue | 63 | 3.7e-03 | 1.000 | 2 | GO:0099560 | BP | synaptic membrane adhesion |
| 231 | darkturquoise | 141 | 2.5e-04 | 1.000 | 2 | GO:0043291 | CC | RAVE complex |
| 232 | darkturquoise | 141 | 4.7e-04 | 1.000 | 18 | GO:0099503 | CC | secretory vesicle |
| 233 | darkturquoise | 141 | 5.9e-04 | 1.000 | 21 | GO:0045202 | CC | synapse |
| 234 | darkturquoise | 141 | 6.0e-04 | 1.000 | 16 | GO:0030141 | CC | secretory granule |
| 235 | darkturquoise | 141 | 8.3e-04 | 1.000 | 2 | GO:0042420 | BP | dopamine catabolic process |
| 236 | darkturquoise | 141 | 8.3e-04 | 1.000 | 2 | GO:0098937 | BP | anterograde dendritic transport |
| 237 | darkturquoise | 141 | 8.3e-04 | 1.000 | 2 | GO:0042105 | CC | alpha-beta T cell receptor complex |
| 238 | darkturquoise | 141 | 1.2e-03 | 1.000 | 2 | GO:0042424 | BP | catecholamine catabolic process |
| 239 | darkturquoise | 141 | 2.9e-03 | 1.000 | 2 | GO:0097470 | CC | ribbon synapse |
| 240 | darkturquoise | 141 | 2.9e-03 | 1.000 | 2 | GO:0035612 | MF | AP-2 adaptor complex binding |
| 241 | darkviolet | 33 | 4.9e-04 | 1.000 | 8 | GO:0009790 | BP | embryo development |
| 242 | darkviolet | 33 | 1.1e-03 | 1.000 | 6 | GO:0043009 | BP | chordate embryonic development |
| 243 | darkviolet | 33 | 1.3e-03 | 1.000 | 6 | GO:0009792 | BP | embryo development ending in birth or egg hatching |
| 244 | darkviolet | 33 | 2.2e-03 | 1.000 | 1 | GO:0002926 | BP | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation |
| 245 | darkviolet | 33 | 2.2e-03 | 1.000 | 1 | GO:0046081 | BP | dUTP catabolic process |
| 246 | darkviolet | 33 | 2.2e-03 | 1.000 | 1 | GO:0071707 | BP | immunoglobulin heavy chain V-D-J recombination |
| 247 | darkviolet | 33 | 2.2e-03 | 1.000 | 1 | GO:1904864 | BP | negative regulation of beta-catenin-TCF complex assembly |
| 248 | darkviolet | 33 | 2.2e-03 | 1.000 | 1 | GO:0004170 | MF | dUTP diphosphatase activity |
| 249 | darkviolet | 33 | 2.2e-03 | 1.000 | 1 | GO:0008269 | MF | JAK pathway signal transduction adaptor activity |
| 250 | darkviolet | 33 | 2.2e-03 | 1.000 | 1 | GO:0018477 | MF | benzaldehyde dehydrogenase (NADP+) activity |
| 251 | firebrick4 | 41 | 2.4e-04 | 1.000 | 23 | GO:0003824 | MF | catalytic activity |
| 252 | firebrick4 | 41 | 9.5e-04 | 1.000 | 7 | GO:0016491 | MF | oxidoreductase activity |
| 253 | firebrick4 | 41 | 2.0e-03 | 1.000 | 12 | GO:0016740 | MF | transferase activity |
| 254 | firebrick4 | 41 | 2.6e-03 | 1.000 | 1 | GO:0018315 | BP | molybdenum incorporation into molybdenum-molybdopterin complex |
| 255 | firebrick4 | 41 | 2.6e-03 | 1.000 | 1 | GO:0045234 | BP | protein palmitoleylation |
| 256 | firebrick4 | 41 | 2.6e-03 | 1.000 | 1 | GO:0071109 | BP | superior temporal gyrus development |
| 257 | firebrick4 | 41 | 2.6e-03 | 1.000 | 1 | GO:0072579 | BP | glycine receptor clustering |
| 258 | firebrick4 | 41 | 2.6e-03 | 1.000 | 1 | GO:0004475 | MF | mannose-1-phosphate guanylyltransferase activity |
| 259 | firebrick4 | 41 | 2.6e-03 | 1.000 | 1 | GO:0004496 | MF | mevalonate kinase activity |
| 260 | firebrick4 | 41 | 2.6e-03 | 1.000 | 1 | GO:0008940 | MF | nitrate reductase activity |
| 261 | floralwhite | 72 | 1.3e-03 | 1.000 | 2 | GO:0032794 | MF | GTPase activating protein binding |
| 262 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:0010070 | BP | zygote asymmetric cell division |
| 263 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:0035611 | BP | protein branching point deglutamylation |
| 264 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:0051697 | BP | protein delipidation |
| 265 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:2000397 | BP | positive regulation of ubiquitin-dependent endocytosis |
| 266 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:0004912 | MF | interleukin-3 receptor activity |
| 267 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:0008663 | MF | 2’,3’-cyclic-nucleotide 2’-phosphodiesterase activity |
| 268 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:0015538 | MF | sialic acid:proton symporter activity |
| 269 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:0016920 | MF | pyroglutamyl-peptidase activity |
| 270 | floralwhite | 72 | 4.9e-03 | 1.000 | 1 | GO:0047734 | MF | CDP-glycerol diphosphatase activity |
| 271 | green | 614 | 1.6e-04 | 1.000 | 13 | GO:0006414 | BP | translational elongation |
| 272 | green | 614 | 1.6e-04 | 1.000 | 36 | GO:0006412 | BP | translation |
| 273 | green | 614 | 2.9e-04 | 1.000 | 9 | GO:0031060 | BP | regulation of histone methylation |
| 274 | green | 614 | 4.1e-04 | 1.000 | 36 | GO:0043043 | BP | peptide biosynthetic process |
| 275 | green | 614 | 4.6e-04 | 1.000 | 4 | GO:1900112 | BP | regulation of histone H3-K9 trimethylation |
| 276 | green | 614 | 7.6e-04 | 1.000 | 42 | GO:0043604 | BP | amide biosynthetic process |
| 277 | green | 614 | 7.8e-04 | 1.000 | 5 | GO:0051570 | BP | regulation of histone H3-K9 methylation |
| 278 | green | 614 | 1.2e-03 | 1.000 | 3 | GO:0008063 | BP | Toll signaling pathway |
| 279 | green | 614 | 1.6e-03 | 1.000 | 5 | GO:0034123 | BP | positive regulation of toll-like receptor signaling pathway |
| 280 | green | 614 | 1.6e-03 | 1.000 | 2 | GO:0031769 | MF | glucagon receptor binding |
| 281 | greenyellow | 269 | 7.8e-04 | 1.000 | 3 | GO:0098799 | CC | outer mitochondrial membrane protein complex |
| 282 | greenyellow | 269 | 1.8e-03 | 1.000 | 2 | GO:0006798 | BP | polyphosphate catabolic process |
| 283 | greenyellow | 269 | 1.8e-03 | 1.000 | 2 | GO:0004309 | MF | exopolyphosphatase activity |
| 284 | greenyellow | 269 | 2.9e-03 | 1.000 | 2 | GO:0006797 | BP | polyphosphate metabolic process |
| 285 | greenyellow | 269 | 2.9e-03 | 1.000 | 2 | GO:1904058 | BP | positive regulation of sensory perception of pain |
| 286 | greenyellow | 269 | 2.9e-03 | 1.000 | 2 | GO:0031492 | MF | nucleosomal DNA binding |
| 287 | greenyellow | 269 | 3.0e-03 | 1.000 | 3 | GO:0005686 | CC | U2 snRNP |
| 288 | greenyellow | 269 | 3.3e-03 | 1.000 | 26 | GO:0000902 | BP | cell morphogenesis |
| 289 | greenyellow | 269 | 4.1e-03 | 1.000 | 3 | GO:0008171 | MF | O-methyltransferase activity |
| 290 | greenyellow | 269 | 4.2e-03 | 1.000 | 4 | GO:0006584 | BP | catecholamine metabolic process |
| 291 | grey | 77 | 1.5e-03 | 1.000 | 5 | GO:0031406 | MF | carboxylic acid binding |
| 292 | grey | 77 | 1.8e-03 | 1.000 | 2 | GO:0001675 | BP | acrosome assembly |
| 293 | grey | 77 | 2.0e-03 | 1.000 | 5 | GO:0043177 | MF | organic acid binding |
| 294 | grey | 77 | 3.2e-03 | 1.000 | 2 | GO:0007289 | BP | spermatid nucleus differentiation |
| 295 | grey | 77 | 4.0e-03 | 1.000 | 2 | GO:0008535 | BP | respiratory chain complex IV assembly |
| 296 | grey | 77 | 4.4e-03 | 1.000 | 2 | GO:0032753 | BP | positive regulation of interleukin-4 production |
| 297 | grey | 77 | 5.0e-03 | 1.000 | 1 | GO:0001576 | BP | globoside biosynthetic process |
| 298 | grey | 77 | 5.0e-03 | 1.000 | 1 | GO:0006784 | BP | heme A biosynthetic process |
| 299 | grey | 77 | 5.0e-03 | 1.000 | 1 | GO:0038195 | BP | urokinase plasminogen activator signaling pathway |
| 300 | grey | 77 | 5.0e-03 | 1.000 | 1 | GO:0043973 | BP | histone H3-K4 acetylation |
| 301 | grey60 | 184 | 2.4e-06 | 0.045 | 6 | GO:1990391 | CC | DNA repair complex |
| 302 | grey60 | 184 | 6.4e-06 | 0.120 | 4 | GO:0000109 | CC | nucleotide-excision repair complex |
| 303 | grey60 | 184 | 7.0e-05 | 1.000 | 6 | GO:0003684 | MF | damaged DNA binding |
| 304 | grey60 | 184 | 4.3e-04 | 1.000 | 2 | GO:0098735 | BP | positive regulation of the force of heart contraction |
| 305 | grey60 | 184 | 4.3e-04 | 1.000 | 2 | GO:0000110 | CC | nucleotide-excision repair factor 1 complex |
| 306 | grey60 | 184 | 4.6e-04 | 1.000 | 3 | GO:0009650 | BP | UV protection |
| 307 | grey60 | 184 | 5.7e-04 | 1.000 | 4 | GO:0006296 | BP | nucleotide-excision repair, DNA incision, 5’-to lesion |
| 308 | grey60 | 184 | 6.5e-04 | 1.000 | 4 | GO:0033683 | BP | nucleotide-excision repair, DNA incision |
| 309 | grey60 | 184 | 8.6e-04 | 1.000 | 2 | GO:0099179 | BP | regulation of synaptic membrane adhesion |
| 310 | grey60 | 184 | 8.6e-04 | 1.000 | 2 | GO:0004784 | MF | superoxide dismutase activity |
| 311 | honeydew | 29 | 2.0e-04 | 1.000 | 2 | GO:0003084 | BP | positive regulation of systemic arterial blood pressure |
| 312 | honeydew | 29 | 9.3e-04 | 1.000 | 3 | GO:0043679 | CC | axon terminus |
| 313 | honeydew | 29 | 1.1e-03 | 1.000 | 2 | GO:0006929 | BP | substrate-dependent cell migration |
| 314 | honeydew | 29 | 1.2e-03 | 1.000 | 2 | GO:0045777 | BP | positive regulation of blood pressure |
| 315 | honeydew | 29 | 1.3e-03 | 1.000 | 3 | GO:0044306 | CC | neuron projection terminus |
| 316 | honeydew | 29 | 1.5e-03 | 1.000 | 17 | GO:0007165 | BP | signal transduction |
| 317 | honeydew | 29 | 1.9e-03 | 1.000 | 1 | GO:0034346 | BP | positive regulation of type III interferon production |
| 318 | honeydew | 29 | 1.9e-03 | 1.000 | 1 | GO:0035483 | BP | gastric emptying |
| 319 | honeydew | 29 | 1.9e-03 | 1.000 | 1 | GO:0043921 | BP | modulation by host of viral transcription |
| 320 | honeydew | 29 | 1.9e-03 | 1.000 | 1 | GO:0120061 | BP | negative regulation of gastric emptying |
| 321 | honeydew1 | 53 | 6.0e-04 | 1.000 | 3 | GO:0045843 | BP | negative regulation of striated muscle tissue development |
| 322 | honeydew1 | 53 | 6.2e-04 | 1.000 | 4 | GO:2001251 | BP | negative regulation of chromosome organization |
| 323 | honeydew1 | 53 | 6.4e-04 | 1.000 | 3 | GO:0048635 | BP | negative regulation of muscle organ development |
| 324 | honeydew1 | 53 | 7.2e-04 | 1.000 | 3 | GO:1901862 | BP | negative regulation of muscle tissue development |
| 325 | honeydew1 | 53 | 9.3e-04 | 1.000 | 2 | GO:0008301 | MF | DNA binding, bending |
| 326 | honeydew1 | 53 | 1.4e-03 | 1.000 | 2 | GO:0005212 | MF | structural constituent of eye lens |
| 327 | honeydew1 | 53 | 2.3e-03 | 1.000 | 3 | GO:0042475 | BP | odontogenesis of dentin-containing tooth |
| 328 | honeydew1 | 53 | 2.9e-03 | 1.000 | 2 | GO:0010614 | BP | negative regulation of cardiac muscle hypertrophy |
| 329 | honeydew1 | 53 | 2.9e-03 | 1.000 | 2 | GO:0055022 | BP | negative regulation of cardiac muscle tissue growth |
| 330 | honeydew1 | 53 | 3.5e-03 | 1.000 | 2 | GO:0014741 | BP | negative regulation of muscle hypertrophy |
| 331 | indianred4 | 40 | 5.4e-04 | 1.000 | 3 | GO:0008306 | BP | associative learning |
| 332 | indianred4 | 40 | 2.3e-03 | 1.000 | 6 | GO:0043065 | BP | positive regulation of apoptotic process |
| 333 | indianred4 | 40 | 2.5e-03 | 1.000 | 6 | GO:0043068 | BP | positive regulation of programmed cell death |
| 334 | indianred4 | 40 | 2.6e-03 | 1.000 | 1 | GO:0006175 | BP | dATP biosynthetic process |
| 335 | indianred4 | 40 | 2.6e-03 | 1.000 | 1 | GO:0019742 | BP | pentacyclic triterpenoid metabolic process |
| 336 | indianred4 | 40 | 2.6e-03 | 1.000 | 1 | GO:1904924 | BP | negative regulation of mitophagy in response to mitochondrial depolarization |
| 337 | indianred4 | 40 | 2.6e-03 | 1.000 | 1 | GO:1905370 | CC | serine-type endopeptidase complex |
| 338 | indianred4 | 40 | 2.6e-03 | 1.000 | 1 | GO:0004001 | MF | adenosine kinase activity |
| 339 | indianred4 | 40 | 3.4e-03 | 1.000 | 2 | GO:0010569 | BP | regulation of double-strand break repair via homologous recombination |
| 340 | indianred4 | 40 | 3.5e-03 | 1.000 | 3 | GO:0007612 | BP | learning |
| 341 | ivory | 75 | 1.9e-03 | 1.000 | 3 | GO:1902108 | BP | regulation of mitochondrial membrane permeability involved in apoptotic process |
| 342 | ivory | 75 | 2.3e-03 | 1.000 | 10 | GO:0061024 | BP | membrane organization |
| 343 | ivory | 75 | 2.5e-03 | 1.000 | 2 | GO:0008553 | MF | proton-exporting ATPase activity, phosphorylative mechanism |
| 344 | ivory | 75 | 3.3e-03 | 1.000 | 2 | GO:0046827 | BP | positive regulation of protein export from nucleus |
| 345 | ivory | 75 | 3.4e-03 | 1.000 | 3 | GO:0046902 | BP | regulation of mitochondrial membrane permeability |
| 346 | ivory | 75 | 4.3e-03 | 1.000 | 3 | GO:0046427 | BP | positive regulation of receptor signaling pathway via JAK-STAT |
| 347 | ivory | 75 | 4.9e-03 | 1.000 | 3 | GO:1904894 | BP | positive regulation of receptor signaling pathway via STAT |
| 348 | ivory | 75 | 5.0e-03 | 1.000 | 2 | GO:0043372 | BP | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| 349 | ivory | 75 | 5.1e-03 | 1.000 | 1 | GO:0010189 | BP | vitamin E biosynthetic process |
| 350 | ivory | 75 | 5.1e-03 | 1.000 | 1 | GO:0018191 | BP | peptidyl-serine octanoylation |
| 351 | lavenderblush2 | 31 | 2.0e-03 | 1.000 | 1 | GO:0000301 | BP | retrograde transport, vesicle recycling within Golgi |
| 352 | lavenderblush2 | 31 | 2.0e-03 | 1.000 | 1 | GO:0003195 | BP | tricuspid valve formation |
| 353 | lavenderblush2 | 31 | 2.0e-03 | 1.000 | 1 | GO:0060377 | BP | negative regulation of mast cell differentiation |
| 354 | lavenderblush2 | 31 | 2.0e-03 | 1.000 | 1 | GO:0045029 | MF | G protein-coupled UDP receptor activity |
| 355 | lavenderblush2 | 31 | 4.0e-03 | 1.000 | 1 | GO:0060375 | BP | regulation of mast cell differentiation |
| 356 | lavenderblush2 | 31 | 4.0e-03 | 1.000 | 1 | GO:0061903 | BP | positive regulation of 1-phosphatidylinositol-3-kinase activity |
| 357 | lavenderblush2 | 31 | 4.0e-03 | 1.000 | 1 | GO:1990498 | CC | mitotic spindle microtubule |
| 358 | lavenderblush2 | 31 | 6.0e-03 | 1.000 | 1 | GO:0003192 | BP | mitral valve formation |
| 359 | lavenderblush2 | 31 | 6.0e-03 | 1.000 | 1 | GO:0010724 | BP | regulation of definitive erythrocyte differentiation |
| 360 | lavenderblush2 | 31 | 6.0e-03 | 1.000 | 1 | GO:0004982 | MF | N-formyl peptide receptor activity |
| 361 | lavenderblush3 | 48 | 1.5e-04 | 1.000 | 2 | GO:0050428 | BP | 3’-phosphoadenosine 5’-phosphosulfate biosynthetic process |
| 362 | lavenderblush3 | 48 | 7.6e-04 | 1.000 | 2 | GO:0098688 | CC | parallel fiber to Purkinje cell synapse |
| 363 | lavenderblush3 | 48 | 1.5e-03 | 1.000 | 2 | GO:0030277 | BP | maintenance of gastrointestinal epithelium |
| 364 | lavenderblush3 | 48 | 1.8e-03 | 1.000 | 2 | GO:0050427 | BP | 3’-phosphoadenosine 5’-phosphosulfate metabolic process |
| 365 | lavenderblush3 | 48 | 2.4e-03 | 1.000 | 2 | GO:0010669 | BP | epithelial structure maintenance |
| 366 | lavenderblush3 | 48 | 3.2e-03 | 1.000 | 1 | GO:0003226 | BP | right ventricular compact myocardium morphogenesis |
| 367 | lavenderblush3 | 48 | 3.2e-03 | 1.000 | 1 | GO:0031247 | BP | actin rod assembly |
| 368 | lavenderblush3 | 48 | 3.2e-03 | 1.000 | 1 | GO:0031635 | BP | adenylate cyclase-inhibiting opioid receptor signaling pathway |
| 369 | lavenderblush3 | 48 | 3.2e-03 | 1.000 | 1 | GO:0004637 | MF | phosphoribosylamine-glycine ligase activity |
| 370 | lavenderblush3 | 48 | 3.2e-03 | 1.000 | 1 | GO:0004641 | MF | phosphoribosylformylglycinamidine cyclo-ligase activity |
| 371 | lightcoral | 45 | 2.0e-03 | 1.000 | 2 | GO:0002082 | BP | regulation of oxidative phosphorylation |
| 372 | lightcoral | 45 | 2.1e-03 | 1.000 | 7 | GO:0017111 | MF | nucleoside-triphosphatase activity |
| 373 | lightcoral | 45 | 2.3e-03 | 1.000 | 22 | GO:0097159 | MF | organic cyclic compound binding |
| 374 | lightcoral | 45 | 2.6e-03 | 1.000 | 3 | GO:0006304 | BP | DNA modification |
| 375 | lightcoral | 45 | 2.9e-03 | 1.000 | 5 | GO:0019693 | BP | ribose phosphate metabolic process |
| 376 | lightcoral | 45 | 2.9e-03 | 1.000 | 1 | GO:0001998 | BP | angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure |
| 377 | lightcoral | 45 | 2.9e-03 | 1.000 | 1 | GO:0005999 | BP | xylulose biosynthetic process |
| 378 | lightcoral | 45 | 2.9e-03 | 1.000 | 1 | GO:0040032 | BP | post-embryonic body morphogenesis |
| 379 | lightcoral | 45 | 2.9e-03 | 1.000 | 1 | GO:0046166 | BP | glyceraldehyde-3-phosphate biosynthetic process |
| 380 | lightcoral | 45 | 2.9e-03 | 1.000 | 1 | GO:0071976 | BP | cell gliding |
| 381 | lightcyan | 199 | 2.8e-03 | 1.000 | 4 | GO:1901185 | BP | negative regulation of ERBB signaling pathway |
| 382 | lightcyan | 199 | 3.5e-03 | 1.000 | 2 | GO:0010898 | BP | positive regulation of triglyceride catabolic process |
| 383 | lightcyan | 199 | 4.6e-03 | 1.000 | 2 | GO:0004726 | MF | non-membrane spanning protein tyrosine phosphatase activity |
| 384 | lightcyan | 199 | 5.8e-03 | 1.000 | 2 | GO:0034770 | BP | histone H4-K20 methylation |
| 385 | lightcyan | 199 | 7.2e-03 | 1.000 | 2 | GO:0021670 | BP | lateral ventricle development |
| 386 | lightcyan | 199 | 7.6e-03 | 1.000 | 5 | GO:0006805 | BP | xenobiotic metabolic process |
| 387 | lightcyan | 199 | 8.8e-03 | 1.000 | 2 | GO:0009437 | BP | carnitine metabolic process |
| 388 | lightcyan | 199 | 8.8e-03 | 1.000 | 2 | GO:0034244 | BP | negative regulation of transcription elongation from RNA polymerase II promoter |
| 389 | lightcyan | 199 | 8.8e-03 | 1.000 | 2 | GO:0032009 | CC | early phagosome |
| 390 | lightcyan | 199 | 8.8e-03 | 1.000 | 2 | GO:0043422 | MF | protein kinase B binding |
| 391 | lightcyan1 | 66 | 1.6e-04 | 1.000 | 3 | GO:0034243 | BP | regulation of transcription elongation from RNA polymerase II promoter |
| 392 | lightcyan1 | 66 | 8.4e-04 | 1.000 | 3 | GO:0032784 | BP | regulation of DNA-templated transcription, elongation |
| 393 | lightcyan1 | 66 | 1.0e-03 | 1.000 | 2 | GO:0042953 | BP | lipoprotein transport |
| 394 | lightcyan1 | 66 | 1.2e-03 | 1.000 | 2 | GO:0032968 | BP | positive regulation of transcription elongation from RNA polymerase II promoter |
| 395 | lightcyan1 | 66 | 1.3e-03 | 1.000 | 4 | GO:0030326 | BP | embryonic limb morphogenesis |
| 396 | lightcyan1 | 66 | 1.8e-03 | 1.000 | 3 | GO:0042733 | BP | embryonic digit morphogenesis |
| 397 | lightcyan1 | 66 | 2.3e-03 | 1.000 | 5 | GO:0016358 | BP | dendrite development |
| 398 | lightcyan1 | 66 | 2.3e-03 | 1.000 | 4 | GO:0035108 | BP | limb morphogenesis |
| 399 | lightcyan1 | 66 | 3.0e-03 | 1.000 | 5 | GO:0030336 | BP | negative regulation of cell migration |
| 400 | lightcyan1 | 66 | 3.9e-03 | 1.000 | 30 | GO:0097159 | MF | organic cyclic compound binding |
| 401 | lightgreen | 173 | 1.1e-04 | 1.000 | 6 | GO:0098839 | CC | postsynaptic density membrane |
| 402 | lightgreen | 173 | 1.3e-04 | 1.000 | 2 | GO:0019777 | MF | Atg12 transferase activity |
| 403 | lightgreen | 173 | 1.5e-04 | 1.000 | 16 | GO:0098794 | CC | postsynapse |
| 404 | lightgreen | 173 | 1.6e-04 | 1.000 | 10 | GO:0045211 | CC | postsynaptic membrane |
| 405 | lightgreen | 173 | 3.7e-04 | 1.000 | 11 | GO:0098984 | CC | neuron to neuron synapse |
| 406 | lightgreen | 173 | 4.1e-04 | 1.000 | 6 | GO:0099634 | CC | postsynaptic specialization membrane |
| 407 | lightgreen | 173 | 6.1e-04 | 1.000 | 7 | GO:0051147 | BP | regulation of muscle cell differentiation |
| 408 | lightgreen | 173 | 6.4e-04 | 1.000 | 4 | GO:0001709 | BP | cell fate determination |
| 409 | lightgreen | 173 | 6.9e-04 | 1.000 | 10 | GO:0014069 | CC | postsynaptic density |
| 410 | lightgreen | 173 | 7.6e-04 | 1.000 | 2 | GO:0032051 | MF | clathrin light chain binding |
| 411 | lightpink3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0061666 | MF | UFM1 ligase activity |
| 412 | lightpink3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0071568 | MF | UFM1 transferase activity |
| 413 | lightpink3 | 30 | 4.0e-03 | 1.000 | 1 | GO:0009258 | BP | 10-formyltetrahydrofolate catabolic process |
| 414 | lightpink3 | 30 | 4.0e-03 | 1.000 | 1 | GO:0004105 | MF | choline-phosphate cytidylyltransferase activity |
| 415 | lightpink3 | 30 | 4.0e-03 | 1.000 | 1 | GO:0004692 | MF | cGMP-dependent protein kinase activity |
| 416 | lightpink3 | 30 | 4.0e-03 | 1.000 | 1 | GO:0016155 | MF | formyltetrahydrofolate dehydrogenase activity |
| 417 | lightpink3 | 30 | 4.0e-03 | 1.000 | 1 | GO:0030158 | MF | protein xylosyltransferase activity |
| 418 | lightpink3 | 30 | 4.0e-03 | 1.000 | 1 | GO:0039552 | MF | RIG-I binding |
| 419 | lightpink3 | 30 | 4.0e-03 | 1.000 | 1 | GO:0072590 | MF | N-acetyl-L-aspartate-L-glutamate ligase activity |
| 420 | lightpink3 | 30 | 6.0e-03 | 1.000 | 1 | GO:1903895 | BP | negative regulation of IRE1-mediated unfolded protein response |
| 421 | lightpink4 | 51 | 1.5e-03 | 1.000 | 2 | GO:0071071 | BP | regulation of phospholipid biosynthetic process |
| 422 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:0000173 | BP | inactivation of MAPK activity involved in osmosensory signaling pathway |
| 423 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:0001080 | BP | nitrogen catabolite activation of transcription from RNA polymerase II promoter |
| 424 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:0034255 | BP | regulation of urea metabolic process |
| 425 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:0038185 | BP | intracellular bile acid receptor signaling pathway |
| 426 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:0046293 | BP | formaldehyde biosynthetic process |
| 427 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:1905188 | BP | positive regulation of metaphase/anaphase transition of meiosis I |
| 428 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:1905349 | BP | ciliary transition zone assembly |
| 429 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:1905695 | BP | positive regulation of phosphatidic acid biosynthetic process |
| 430 | lightpink4 | 51 | 3.4e-03 | 1.000 | 1 | GO:2000213 | BP | positive regulation of glutamate metabolic process |
| 431 | lightsteelblue | 47 | 9.9e-05 | 1.000 | 2 | GO:0071332 | BP | cellular response to fructose stimulus |
| 432 | lightsteelblue | 47 | 2.7e-04 | 1.000 | 2 | GO:0009750 | BP | response to fructose |
| 433 | lightsteelblue | 47 | 4.4e-04 | 1.000 | 2 | GO:0051024 | BP | positive regulation of immunoglobulin secretion |
| 434 | lightsteelblue | 47 | 8.8e-04 | 1.000 | 2 | GO:0051023 | BP | regulation of immunoglobulin secretion |
| 435 | lightsteelblue | 47 | 1.0e-03 | 1.000 | 2 | GO:0002070 | BP | epithelial cell maturation |
| 436 | lightsteelblue | 47 | 1.3e-03 | 1.000 | 2 | GO:0048305 | BP | immunoglobulin secretion |
| 437 | lightsteelblue | 47 | 2.2e-03 | 1.000 | 2 | GO:0050855 | BP | regulation of B cell receptor signaling pathway |
| 438 | lightsteelblue | 47 | 2.2e-03 | 1.000 | 2 | GO:0016628 | MF | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor |
| 439 | lightsteelblue | 47 | 2.5e-03 | 1.000 | 4 | GO:0043177 | MF | organic acid binding |
| 440 | lightsteelblue | 47 | 3.2e-03 | 1.000 | 1 | GO:0034474 | BP | U2 snRNA 3’-end processing |
| 441 | lightsteelblue1 | 75 | 1.0e-06 | 0.018 | 7 | GO:0017148 | BP | negative regulation of translation |
| 442 | lightsteelblue1 | 75 | 1.4e-06 | 0.026 | 10 | GO:0006417 | BP | regulation of translation |
| 443 | lightsteelblue1 | 75 | 3.0e-05 | 0.550 | 8 | GO:0006402 | BP | mRNA catabolic process |
| 444 | lightsteelblue1 | 75 | 6.5e-05 | 1.000 | 4 | GO:0061014 | BP | positive regulation of mRNA catabolic process |
| 445 | lightsteelblue1 | 75 | 6.8e-05 | 1.000 | 8 | GO:0006401 | BP | RNA catabolic process |
| 446 | lightsteelblue1 | 75 | 7.7e-05 | 1.000 | 10 | GO:0006412 | BP | translation |
| 447 | lightsteelblue1 | 75 | 8.6e-05 | 1.000 | 10 | GO:0010608 | BP | posttranscriptional regulation of gene expression |
| 448 | lightsteelblue1 | 75 | 1.2e-04 | 1.000 | 10 | GO:0043043 | BP | peptide biosynthetic process |
| 449 | lightsteelblue1 | 75 | 1.8e-04 | 1.000 | 11 | GO:0043604 | BP | amide biosynthetic process |
| 450 | lightsteelblue1 | 75 | 2.0e-04 | 1.000 | 4 | GO:0000288 | BP | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| 451 | lightyellow | 172 | 3.3e-04 | 1.000 | 5 | GO:0000245 | BP | spliceosomal complex assembly |
| 452 | lightyellow | 172 | 3.8e-04 | 1.000 | 2 | GO:0001887 | BP | selenium compound metabolic process |
| 453 | lightyellow | 172 | 7.2e-04 | 1.000 | 3 | GO:0035461 | BP | vitamin transmembrane transport |
| 454 | lightyellow | 172 | 7.6e-04 | 1.000 | 2 | GO:0051939 | BP | gamma-aminobutyric acid import |
| 455 | lightyellow | 172 | 1.3e-03 | 1.000 | 2 | GO:0000243 | CC | commitment complex |
| 456 | lightyellow | 172 | 1.3e-03 | 1.000 | 2 | GO:0015185 | MF | gamma-aminobutyric acid transmembrane transporter activity |
| 457 | lightyellow | 172 | 1.3e-03 | 1.000 | 2 | GO:1990446 | MF | U1 snRNP binding |
| 458 | lightyellow | 172 | 1.9e-03 | 1.000 | 2 | GO:0001915 | BP | negative regulation of T cell mediated cytotoxicity |
| 459 | lightyellow | 172 | 1.9e-03 | 1.000 | 2 | GO:0042723 | BP | thiamine-containing compound metabolic process |
| 460 | lightyellow | 172 | 1.9e-03 | 1.000 | 2 | GO:2000210 | BP | positive regulation of anoikis |
| 461 | magenta | 343 | 3.9e-06 | 0.071 | 4 | GO:0004024 | MF | alcohol dehydrogenase activity, zinc-dependent |
| 462 | magenta | 343 | 1.7e-05 | 0.320 | 4 | GO:0004022 | MF | alcohol dehydrogenase (NAD+) activity |
| 463 | magenta | 343 | 3.1e-05 | 0.560 | 4 | GO:0018455 | MF | alcohol dehydrogenase [NAD(P)+] activity |
| 464 | magenta | 343 | 7.8e-05 | 1.000 | 4 | GO:0006069 | BP | ethanol oxidation |
| 465 | magenta | 343 | 2.8e-04 | 1.000 | 10 | GO:0050728 | BP | negative regulation of inflammatory response |
| 466 | magenta | 343 | 5.2e-04 | 1.000 | 2 | GO:0032197 | BP | transposition, RNA-mediated |
| 467 | magenta | 343 | 5.2e-04 | 1.000 | 2 | GO:0070859 | BP | positive regulation of bile acid biosynthetic process |
| 468 | magenta | 343 | 6.1e-04 | 1.000 | 3 | GO:0034115 | BP | negative regulation of heterotypic cell-cell adhesion |
| 469 | magenta | 343 | 6.3e-04 | 1.000 | 4 | GO:0004745 | MF | retinol dehydrogenase activity |
| 470 | magenta | 343 | 8.5e-04 | 1.000 | 5 | GO:0034142 | BP | toll-like receptor 4 signaling pathway |
| 471 | magenta4 | 31 | 3.7e-04 | 1.000 | 2 | GO:0006825 | BP | copper ion transport |
| 472 | magenta4 | 31 | 9.7e-04 | 1.000 | 2 | GO:0008266 | MF | poly(U) RNA binding |
| 473 | magenta4 | 31 | 1.2e-03 | 1.000 | 2 | GO:0008187 | MF | poly-pyrimidine tract binding |
| 474 | magenta4 | 31 | 1.9e-03 | 1.000 | 1 | GO:0018467 | MF | formaldehyde dehydrogenase activity |
| 475 | magenta4 | 31 | 1.9e-03 | 1.000 | 1 | GO:0019119 | MF | phenanthrene-9,10-epoxide hydrolase activity |
| 476 | magenta4 | 31 | 1.9e-03 | 1.000 | 1 | GO:1990272 | MF | anti-Mullerian hormone receptor activity |
| 477 | magenta4 | 31 | 3.9e-03 | 1.000 | 2 | GO:0006081 | BP | cellular aldehyde metabolic process |
| 478 | magenta4 | 31 | 3.9e-03 | 1.000 | 1 | GO:1990262 | BP | anti-Mullerian hormone signaling pathway |
| 479 | magenta4 | 31 | 3.9e-03 | 1.000 | 1 | GO:0010370 | CC | perinucleolar chromocenter |
| 480 | magenta4 | 31 | 3.9e-03 | 1.000 | 1 | GO:0048269 | CC | methionine adenosyltransferase complex |
| 481 | maroon | 52 | 1.4e-04 | 1.000 | 4 | GO:0005200 | MF | structural constituent of cytoskeleton |
| 482 | maroon | 52 | 3.2e-04 | 1.000 | 2 | GO:0034663 | CC | endoplasmic reticulum chaperone complex |
| 483 | maroon | 52 | 3.3e-04 | 1.000 | 3 | GO:0030195 | BP | negative regulation of blood coagulation |
| 484 | maroon | 52 | 3.3e-04 | 1.000 | 3 | GO:1900047 | BP | negative regulation of hemostasis |
| 485 | maroon | 52 | 3.3e-04 | 1.000 | 10 | GO:0008092 | MF | cytoskeletal protein binding |
| 486 | maroon | 52 | 3.8e-04 | 1.000 | 3 | GO:0050819 | BP | negative regulation of coagulation |
| 487 | maroon | 52 | 1.1e-03 | 1.000 | 3 | GO:0061045 | BP | negative regulation of wound healing |
| 488 | maroon | 52 | 1.5e-03 | 1.000 | 3 | GO:0030193 | BP | regulation of blood coagulation |
| 489 | maroon | 52 | 2.1e-03 | 1.000 | 4 | GO:0001726 | CC | ruffle |
| 490 | maroon | 52 | 2.1e-03 | 1.000 | 2 | GO:0019430 | BP | removal of superoxide radicals |
| 491 | mediumorchid | 48 | 1.7e-03 | 1.000 | 2 | GO:0038187 | MF | pattern recognition receptor activity |
| 492 | mediumorchid | 48 | 2.1e-03 | 1.000 | 2 | GO:0001671 | MF | ATPase activator activity |
| 493 | mediumorchid | 48 | 2.9e-03 | 1.000 | 2 | GO:0014044 | BP | Schwann cell development |
| 494 | mediumorchid | 48 | 3.1e-03 | 1.000 | 1 | GO:0003167 | BP | atrioventricular bundle cell differentiation |
| 495 | mediumorchid | 48 | 3.1e-03 | 1.000 | 1 | GO:0021618 | BP | hypoglossal nerve morphogenesis |
| 496 | mediumorchid | 48 | 3.1e-03 | 1.000 | 1 | GO:0051308 | BP | male meiosis chromosome separation |
| 497 | mediumorchid | 48 | 3.1e-03 | 1.000 | 1 | GO:0044218 | CC | other organism cell membrane |
| 498 | mediumorchid | 48 | 3.1e-03 | 1.000 | 1 | GO:0030549 | MF | acetylcholine receptor activator activity |
| 499 | mediumorchid | 48 | 3.1e-03 | 1.000 | 1 | GO:0046811 | MF | histone deacetylase inhibitor activity |
| 500 | mediumorchid | 48 | 4.7e-03 | 1.000 | 2 | GO:0014037 | BP | Schwann cell differentiation |
| 501 | mediumpurple2 | 46 | 2.4e-04 | 1.000 | 2 | GO:0035815 | BP | positive regulation of renal sodium excretion |
| 502 | mediumpurple2 | 46 | 3.1e-04 | 1.000 | 2 | GO:0035810 | BP | positive regulation of urine volume |
| 503 | mediumpurple2 | 46 | 4.7e-04 | 1.000 | 2 | GO:0030207 | BP | chondroitin sulfate catabolic process |
| 504 | mediumpurple2 | 46 | 4.7e-04 | 1.000 | 2 | GO:0030208 | BP | dermatan sulfate biosynthetic process |
| 505 | mediumpurple2 | 46 | 5.6e-04 | 1.000 | 2 | GO:0030205 | BP | dermatan sulfate metabolic process |
| 506 | mediumpurple2 | 46 | 6.6e-04 | 1.000 | 2 | GO:0050651 | BP | dermatan sulfate proteoglycan biosynthetic process |
| 507 | mediumpurple2 | 46 | 7.7e-04 | 1.000 | 2 | GO:0035813 | BP | regulation of renal sodium excretion |
| 508 | mediumpurple2 | 46 | 7.7e-04 | 1.000 | 2 | GO:0050655 | BP | dermatan sulfate proteoglycan metabolic process |
| 509 | mediumpurple2 | 46 | 8.9e-04 | 1.000 | 2 | GO:0035809 | BP | regulation of urine volume |
| 510 | mediumpurple2 | 46 | 1.0e-03 | 1.000 | 2 | GO:0035812 | BP | renal sodium excretion |
| 511 | mediumpurple3 | 76 | 7.1e-04 | 1.000 | 2 | GO:0070475 | BP | rRNA base methylation |
| 512 | mediumpurple3 | 76 | 1.9e-03 | 1.000 | 2 | GO:0070411 | MF | I-SMAD binding |
| 513 | mediumpurple3 | 76 | 2.3e-03 | 1.000 | 2 | GO:0016863 | MF | intramolecular oxidoreductase activity, transposing C=C bonds |
| 514 | mediumpurple3 | 76 | 3.0e-03 | 1.000 | 2 | GO:0097381 | CC | photoreceptor disc membrane |
| 515 | mediumpurple3 | 76 | 3.8e-03 | 1.000 | 2 | GO:0031664 | BP | regulation of lipopolysaccharide-mediated signaling pathway |
| 516 | mediumpurple3 | 76 | 5.1e-03 | 1.000 | 2 | GO:0031167 | BP | rRNA methylation |
| 517 | mediumpurple3 | 76 | 5.1e-03 | 1.000 | 1 | GO:0010607 | BP | negative regulation of cytoplasmic mRNA processing body assembly |
| 518 | mediumpurple3 | 76 | 5.1e-03 | 1.000 | 1 | GO:0015689 | BP | molybdate ion transport |
| 519 | mediumpurple3 | 76 | 5.1e-03 | 1.000 | 1 | GO:0061078 | BP | positive regulation of prostaglandin secretion involved in immune response |
| 520 | mediumpurple3 | 76 | 5.1e-03 | 1.000 | 1 | GO:0061188 | BP | negative regulation of ribosomal DNA heterochromatin assembly |
| 521 | midnightblue | 218 | 1.6e-04 | 1.000 | 3 | GO:0050910 | BP | detection of mechanical stimulus involved in sensory perception of sound |
| 522 | midnightblue | 218 | 1.6e-04 | 1.000 | 3 | GO:0071374 | BP | cellular response to parathyroid hormone stimulus |
| 523 | midnightblue | 218 | 3.4e-04 | 1.000 | 3 | GO:0032000 | BP | positive regulation of fatty acid beta-oxidation |
| 524 | midnightblue | 218 | 3.4e-04 | 1.000 | 3 | GO:0071107 | BP | response to parathyroid hormone |
| 525 | midnightblue | 218 | 4.4e-04 | 1.000 | 13 | GO:0051098 | BP | regulation of binding |
| 526 | midnightblue | 218 | 6.2e-04 | 1.000 | 2 | GO:0060171 | CC | stereocilium membrane |
| 527 | midnightblue | 218 | 7.7e-04 | 1.000 | 4 | GO:0046320 | BP | regulation of fatty acid oxidation |
| 528 | midnightblue | 218 | 7.8e-04 | 1.000 | 3 | GO:0016918 | MF | retinal binding |
| 529 | midnightblue | 218 | 8.9e-04 | 1.000 | 9 | GO:0043393 | BP | regulation of protein binding |
| 530 | midnightblue | 218 | 9.8e-04 | 1.000 | 3 | GO:0046321 | BP | positive regulation of fatty acid oxidation |
| 531 | navajowhite1 | 35 | 6.6e-04 | 1.000 | 4 | GO:1902749 | BP | regulation of cell cycle G2/M phase transition |
| 532 | navajowhite1 | 35 | 7.9e-04 | 1.000 | 3 | GO:1902750 | BP | negative regulation of cell cycle G2/M phase transition |
| 533 | navajowhite1 | 35 | 1.7e-03 | 1.000 | 4 | GO:0044839 | BP | cell cycle G2/M phase transition |
| 534 | navajowhite1 | 35 | 1.7e-03 | 1.000 | 2 | GO:1902751 | BP | positive regulation of cell cycle G2/M phase transition |
| 535 | navajowhite1 | 35 | 1.8e-03 | 1.000 | 2 | GO:0031572 | BP | G2 DNA damage checkpoint |
| 536 | navajowhite1 | 35 | 2.3e-03 | 1.000 | 3 | GO:0042770 | BP | signal transduction in response to DNA damage |
| 537 | navajowhite1 | 35 | 2.3e-03 | 1.000 | 1 | GO:0001680 | BP | tRNA 3’-terminal CCA addition |
| 538 | navajowhite1 | 35 | 2.3e-03 | 1.000 | 1 | GO:0007344 | BP | pronuclear fusion |
| 539 | navajowhite1 | 35 | 2.3e-03 | 1.000 | 1 | GO:0086072 | BP | AV node cell-bundle of His cell adhesion involved in cell communication |
| 540 | navajowhite1 | 35 | 2.3e-03 | 1.000 | 1 | GO:0000386 | MF | second spliceosomal transesterification activity |
| 541 | navajowhite2 | 48 | 5.8e-04 | 1.000 | 2 | GO:0003161 | BP | cardiac conduction system development |
| 542 | navajowhite2 | 48 | 5.8e-04 | 1.000 | 2 | GO:0043619 | BP | regulation of transcription from RNA polymerase II promoter in response to oxidative stress |
| 543 | navajowhite2 | 48 | 8.2e-04 | 1.000 | 2 | GO:0045836 | BP | positive regulation of meiotic nuclear division |
| 544 | navajowhite2 | 48 | 9.6e-04 | 1.000 | 2 | GO:0070628 | MF | proteasome binding |
| 545 | navajowhite2 | 48 | 2.4e-03 | 1.000 | 2 | GO:0051446 | BP | positive regulation of meiotic cell cycle |
| 546 | navajowhite2 | 48 | 3.1e-03 | 1.000 | 2 | GO:0080025 | MF | phosphatidylinositol-3,5-bisphosphate binding |
| 547 | navajowhite2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0003165 | BP | Purkinje myocyte development |
| 548 | navajowhite2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0009405 | BP | pathogenesis |
| 549 | navajowhite2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0016243 | BP | regulation of autophagosome size |
| 550 | navajowhite2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0036164 | BP | cell-abiotic substrate adhesion |
| 551 | orange | 110 | 6.6e-04 | 1.000 | 3 | GO:0045499 | MF | chemorepellent activity |
| 552 | orange | 110 | 2.3e-03 | 1.000 | 18 | GO:0005102 | MF | signaling receptor binding |
| 553 | orange | 110 | 2.5e-03 | 1.000 | 3 | GO:0050919 | BP | negative chemotaxis |
| 554 | orange | 110 | 2.7e-03 | 1.000 | 2 | GO:1905516 | BP | positive regulation of fertilization |
| 555 | orange | 110 | 3.0e-03 | 1.000 | 3 | GO:0033003 | BP | regulation of mast cell activation |
| 556 | orange | 110 | 3.2e-03 | 1.000 | 2 | GO:0009313 | BP | oligosaccharide catabolic process |
| 557 | orange | 110 | 3.5e-03 | 1.000 | 7 | GO:0000209 | BP | protein polyubiquitination |
| 558 | orange | 110 | 3.8e-03 | 1.000 | 2 | GO:0032045 | CC | guanyl-nucleotide exchange factor complex |
| 559 | orange | 110 | 4.4e-03 | 1.000 | 2 | GO:0006474 | BP | N-terminal protein amino acid acetylation |
| 560 | orange | 110 | 4.4e-03 | 1.000 | 2 | GO:0030889 | BP | negative regulation of B cell proliferation |
| 561 | orangered3 | 43 | 2.6e-04 | 1.000 | 3 | GO:0051496 | BP | positive regulation of stress fiber assembly |
| 562 | orangered3 | 43 | 4.3e-04 | 1.000 | 3 | GO:0032233 | BP | positive regulation of actin filament bundle assembly |
| 563 | orangered3 | 43 | 7.1e-04 | 1.000 | 3 | GO:0016811 | MF | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |
| 564 | orangered3 | 43 | 1.0e-03 | 1.000 | 4 | GO:0031032 | BP | actomyosin structure organization |
| 565 | orangered3 | 43 | 1.1e-03 | 1.000 | 3 | GO:0048041 | BP | focal adhesion assembly |
| 566 | orangered3 | 43 | 1.2e-03 | 1.000 | 3 | GO:0051492 | BP | regulation of stress fiber assembly |
| 567 | orangered3 | 43 | 1.5e-03 | 1.000 | 3 | GO:0048661 | BP | positive regulation of smooth muscle cell proliferation |
| 568 | orangered3 | 43 | 1.6e-03 | 1.000 | 3 | GO:0007229 | BP | integrin-mediated signaling pathway |
| 569 | orangered3 | 43 | 1.8e-03 | 1.000 | 3 | GO:0032231 | BP | regulation of actin filament bundle assembly |
| 570 | orangered3 | 43 | 2.0e-03 | 1.000 | 3 | GO:0007044 | BP | cell-substrate junction assembly |
| 571 | orangered4 | 82 | 9.1e-04 | 1.000 | 3 | GO:0004520 | MF | endodeoxyribonuclease activity |
| 572 | orangered4 | 82 | 1.3e-03 | 1.000 | 3 | GO:0033003 | BP | regulation of mast cell activation |
| 573 | orangered4 | 82 | 1.9e-03 | 1.000 | 5 | GO:0016758 | MF | transferase activity, transferring hexosyl groups |
| 574 | orangered4 | 82 | 2.6e-03 | 1.000 | 3 | GO:0004536 | MF | deoxyribonuclease activity |
| 575 | orangered4 | 82 | 3.0e-03 | 1.000 | 2 | GO:0006491 | BP | N-glycan processing |
| 576 | orangered4 | 82 | 3.4e-03 | 1.000 | 2 | GO:0005212 | MF | structural constituent of eye lens |
| 577 | orangered4 | 82 | 3.5e-03 | 1.000 | 3 | GO:0045576 | BP | mast cell activation |
| 578 | orangered4 | 82 | 3.8e-03 | 1.000 | 2 | GO:0045954 | BP | positive regulation of natural killer cell mediated cytotoxicity |
| 579 | orangered4 | 82 | 4.2e-03 | 1.000 | 12 | GO:1901135 | BP | carbohydrate derivative metabolic process |
| 580 | orangered4 | 82 | 4.4e-03 | 1.000 | 6 | GO:0009101 | BP | glycoprotein biosynthetic process |
| 581 | paleturquoise | 89 | 4.2e-05 | 0.770 | 5 | GO:1900034 | BP | regulation of cellular response to heat |
| 582 | paleturquoise | 89 | 3.3e-04 | 1.000 | 5 | GO:0034605 | BP | cellular response to heat |
| 583 | paleturquoise | 89 | 3.6e-04 | 1.000 | 5 | GO:0042476 | BP | odontogenesis |
| 584 | paleturquoise | 89 | 4.1e-04 | 1.000 | 3 | GO:0032201 | BP | telomere maintenance via semi-conservative replication |
| 585 | paleturquoise | 89 | 4.1e-04 | 1.000 | 3 | GO:0030894 | CC | replisome |
| 586 | paleturquoise | 89 | 9.5e-04 | 1.000 | 11 | GO:0060322 | BP | head development |
| 587 | paleturquoise | 89 | 1.2e-03 | 1.000 | 6 | GO:0031334 | BP | positive regulation of protein-containing complex assembly |
| 588 | paleturquoise | 89 | 1.3e-03 | 1.000 | 7 | GO:0001666 | BP | response to hypoxia |
| 589 | paleturquoise | 89 | 1.4e-03 | 1.000 | 5 | GO:0009408 | BP | response to heat |
| 590 | paleturquoise | 89 | 1.4e-03 | 1.000 | 3 | GO:0043596 | CC | nuclear replication fork |
| 591 | palevioletred2 | 32 | 1.7e-03 | 1.000 | 5 | GO:0005929 | CC | cilium |
| 592 | palevioletred2 | 32 | 1.8e-03 | 1.000 | 1 | GO:0014737 | BP | positive regulation of muscle atrophy |
| 593 | palevioletred2 | 32 | 1.8e-03 | 1.000 | 1 | GO:0052591 | MF | sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity |
| 594 | palevioletred2 | 32 | 3.6e-03 | 1.000 | 1 | GO:0001544 | BP | initiation of primordial ovarian follicle growth |
| 595 | palevioletred2 | 32 | 3.6e-03 | 1.000 | 1 | GO:0006127 | BP | glycerophosphate shuttle |
| 596 | palevioletred2 | 32 | 3.6e-03 | 1.000 | 1 | GO:0033082 | BP | regulation of extrathymic T cell differentiation |
| 597 | palevioletred2 | 32 | 3.6e-03 | 1.000 | 1 | GO:0071386 | BP | cellular response to corticosterone stimulus |
| 598 | palevioletred2 | 32 | 3.6e-03 | 1.000 | 1 | GO:1903723 | BP | negative regulation of centriole elongation |
| 599 | palevioletred2 | 32 | 3.6e-03 | 1.000 | 1 | GO:0004368 | MF | glycerol-3-phosphate dehydrogenase (quinone) activity |
| 600 | palevioletred2 | 32 | 3.6e-03 | 1.000 | 1 | GO:0034246 | MF | mitochondrial transcription factor activity |
| 601 | palevioletred3 | 53 | 1.2e-04 | 1.000 | 2 | GO:2000563 | BP | positive regulation of CD4-positive, alpha-beta T cell proliferation |
| 602 | palevioletred3 | 53 | 3.2e-04 | 1.000 | 3 | GO:0034198 | BP | cellular response to amino acid starvation |
| 603 | palevioletred3 | 53 | 4.0e-04 | 1.000 | 3 | GO:1990928 | BP | response to amino acid starvation |
| 604 | palevioletred3 | 53 | 4.3e-04 | 1.000 | 2 | GO:0140161 | MF | monocarboxylate:sodium symporter activity |
| 605 | palevioletred3 | 53 | 2.0e-03 | 1.000 | 2 | GO:0035743 | BP | CD4-positive, alpha-beta T cell cytokine production |
| 606 | palevioletred3 | 53 | 2.5e-03 | 1.000 | 2 | GO:0046641 | BP | positive regulation of alpha-beta T cell proliferation |
| 607 | palevioletred3 | 53 | 3.5e-03 | 1.000 | 2 | GO:0005343 | MF | organic acid:sodium symporter activity |
| 608 | palevioletred3 | 53 | 3.5e-03 | 1.000 | 1 | GO:0010722 | BP | regulation of ferrochelatase activity |
| 609 | palevioletred3 | 53 | 3.5e-03 | 1.000 | 1 | GO:0015730 | BP | propanoate transport |
| 610 | palevioletred3 | 53 | 3.5e-03 | 1.000 | 1 | GO:0015913 | BP | short-chain fatty acid import |
| 611 | pink | 444 | 8.7e-05 | 1.000 | 7 | GO:0030159 | MF | signaling receptor complex adaptor activity |
| 612 | pink | 444 | 3.7e-04 | 1.000 | 5 | GO:0090140 | BP | regulation of mitochondrial fission |
| 613 | pink | 444 | 5.8e-04 | 1.000 | 6 | GO:0000266 | BP | mitochondrial fission |
| 614 | pink | 444 | 5.8e-04 | 1.000 | 4 | GO:0090148 | BP | membrane fission |
| 615 | pink | 444 | 8.1e-04 | 1.000 | 3 | GO:0048312 | BP | intracellular distribution of mitochondria |
| 616 | pink | 444 | 8.6e-04 | 1.000 | 2 | GO:0035712 | BP | T-helper 2 cell activation |
| 617 | pink | 444 | 8.6e-04 | 1.000 | 2 | GO:1902823 | BP | negative regulation of late endosome to lysosome transport |
| 618 | pink | 444 | 8.6e-04 | 1.000 | 2 | GO:0099073 | CC | mitochondrion-derived vesicle |
| 619 | pink | 444 | 1.1e-03 | 1.000 | 8 | GO:0097061 | BP | dendritic spine organization |
| 620 | pink | 444 | 1.3e-03 | 1.000 | 3 | GO:0014041 | BP | regulation of neuron maturation |
| 621 | plum | 46 | 1.3e-03 | 1.000 | 2 | GO:0000979 | MF | RNA polymerase II core promoter sequence-specific DNA binding |
| 622 | plum | 46 | 1.4e-03 | 1.000 | 2 | GO:1904666 | BP | regulation of ubiquitin protein ligase activity |
| 623 | plum | 46 | 1.8e-03 | 1.000 | 4 | GO:1902749 | BP | regulation of cell cycle G2/M phase transition |
| 624 | plum | 46 | 1.9e-03 | 1.000 | 2 | GO:0060765 | BP | regulation of androgen receptor signaling pathway |
| 625 | plum | 46 | 2.1e-03 | 1.000 | 5 | GO:0060271 | BP | cilium assembly |
| 626 | plum | 46 | 2.2e-03 | 1.000 | 15 | GO:0002376 | BP | immune system process |
| 627 | plum | 46 | 2.3e-03 | 1.000 | 2 | GO:0032897 | BP | negative regulation of viral transcription |
| 628 | plum | 46 | 2.5e-03 | 1.000 | 4 | GO:0045637 | BP | regulation of myeloid cell differentiation |
| 629 | plum | 46 | 2.6e-03 | 1.000 | 5 | GO:0044782 | BP | cilium organization |
| 630 | plum | 46 | 2.7e-03 | 1.000 | 2 | GO:0046496 | BP | nicotinamide nucleotide metabolic process |
| 631 | plum1 | 83 | 1.3e-03 | 1.000 | 2 | GO:0046929 | BP | negative regulation of neurotransmitter secretion |
| 632 | plum1 | 83 | 1.4e-03 | 1.000 | 11 | GO:0061024 | BP | membrane organization |
| 633 | plum1 | 83 | 1.6e-03 | 1.000 | 6 | GO:0005770 | CC | late endosome |
| 634 | plum1 | 83 | 1.6e-03 | 1.000 | 2 | GO:2000774 | BP | positive regulation of cellular senescence |
| 635 | plum1 | 83 | 1.9e-03 | 1.000 | 2 | GO:0001778 | BP | plasma membrane repair |
| 636 | plum1 | 83 | 1.9e-03 | 1.000 | 2 | GO:0005024 | MF | transforming growth factor beta-activated receptor activity |
| 637 | plum1 | 83 | 2.3e-03 | 1.000 | 2 | GO:0090343 | BP | positive regulation of cell aging |
| 638 | plum1 | 83 | 2.6e-03 | 1.000 | 2 | GO:0045236 | MF | CXCR chemokine receptor binding |
| 639 | plum1 | 83 | 3.0e-03 | 1.000 | 2 | GO:0050765 | BP | negative regulation of phagocytosis |
| 640 | plum1 | 83 | 3.9e-03 | 1.000 | 2 | GO:0004675 | MF | transmembrane receptor protein serine/threonine kinase activity |
| 641 | plum2 | 61 | 5.3e-05 | 0.970 | 9 | GO:0007264 | BP | small GTPase mediated signal transduction |
| 642 | plum2 | 61 | 9.8e-05 | 1.000 | 3 | GO:0003707 | MF | steroid hormone receptor activity |
| 643 | plum2 | 61 | 2.0e-04 | 1.000 | 3 | GO:0046320 | BP | regulation of fatty acid oxidation |
| 644 | plum2 | 61 | 3.5e-04 | 1.000 | 4 | GO:0071887 | BP | leukocyte apoptotic process |
| 645 | plum2 | 61 | 4.4e-04 | 1.000 | 5 | GO:1901215 | BP | negative regulation of neuron death |
| 646 | plum2 | 61 | 6.0e-04 | 1.000 | 4 | GO:0009062 | BP | fatty acid catabolic process |
| 647 | plum2 | 61 | 7.2e-04 | 1.000 | 6 | GO:0010721 | BP | negative regulation of cell development |
| 648 | plum2 | 61 | 7.5e-04 | 1.000 | 6 | GO:0051056 | BP | regulation of small GTPase mediated signal transduction |
| 649 | plum2 | 61 | 1.4e-03 | 1.000 | 2 | GO:0046321 | BP | positive regulation of fatty acid oxidation |
| 650 | plum2 | 61 | 2.2e-03 | 1.000 | 2 | GO:0031998 | BP | regulation of fatty acid beta-oxidation |
| 651 | plum3 | 34 | 5.6e-04 | 1.000 | 2 | GO:0031290 | BP | retinal ganglion cell axon guidance |
| 652 | plum3 | 34 | 2.2e-03 | 1.000 | 1 | GO:0060007 | BP | linear vestibuloocular reflex |
| 653 | plum3 | 34 | 2.2e-03 | 1.000 | 1 | GO:1902870 | BP | negative regulation of amacrine cell differentiation |
| 654 | plum3 | 34 | 2.2e-03 | 1.000 | 1 | GO:0070611 | MF | histone methyltransferase activity (H3-R2 specific) |
| 655 | plum3 | 34 | 2.2e-03 | 1.000 | 1 | GO:0070612 | MF | histone methyltransferase activity (H2A-R3 specific) |
| 656 | plum3 | 34 | 3.7e-03 | 1.000 | 2 | GO:0008038 | BP | neuron recognition |
| 657 | plum3 | 34 | 4.4e-03 | 1.000 | 1 | GO:0034970 | BP | histone H3-R2 methylation |
| 658 | plum3 | 34 | 4.4e-03 | 1.000 | 1 | GO:0050925 | BP | negative regulation of negative chemotaxis |
| 659 | plum3 | 34 | 4.4e-03 | 1.000 | 1 | GO:0061364 | BP | apoptotic process involved in luteolysis |
| 660 | plum3 | 34 | 4.4e-03 | 1.000 | 1 | GO:1904178 | BP | negative regulation of adipose tissue development |
| 661 | purple | 321 | 4.8e-04 | 1.000 | 13 | GO:0005126 | MF | cytokine receptor binding |
| 662 | purple | 321 | 7.3e-04 | 1.000 | 3 | GO:0036462 | BP | TRAIL-activated apoptotic signaling pathway |
| 663 | purple | 321 | 1.3e-03 | 1.000 | 2 | GO:1901671 | BP | positive regulation of superoxide dismutase activity |
| 664 | purple | 321 | 1.3e-03 | 1.000 | 2 | GO:0008177 | MF | succinate dehydrogenase (ubiquinone) activity |
| 665 | purple | 321 | 1.9e-03 | 1.000 | 8 | GO:0002687 | BP | positive regulation of leukocyte migration |
| 666 | purple | 321 | 2.6e-03 | 1.000 | 2 | GO:0043400 | BP | cortisol secretion |
| 667 | purple | 321 | 2.6e-03 | 1.000 | 2 | GO:1901668 | BP | regulation of superoxide dismutase activity |
| 668 | purple | 321 | 2.6e-03 | 1.000 | 2 | GO:0090571 | CC | RNA polymerase II transcription repressor complex |
| 669 | purple | 321 | 2.6e-03 | 1.000 | 2 | GO:0031731 | MF | CCR6 chemokine receptor binding |
| 670 | purple | 321 | 2.7e-03 | 1.000 | 10 | GO:0005125 | MF | cytokine activity |
| 671 | red | 542 | 2.2e-04 | 1.000 | 8 | GO:0032206 | BP | positive regulation of telomere maintenance |
| 672 | red | 542 | 2.8e-04 | 1.000 | 4 | GO:2001204 | BP | regulation of osteoclast development |
| 673 | red | 542 | 4.2e-04 | 1.000 | 3 | GO:2001205 | BP | negative regulation of osteoclast development |
| 674 | red | 542 | 5.8e-04 | 1.000 | 8 | GO:0045670 | BP | regulation of osteoclast differentiation |
| 675 | red | 542 | 8.2e-04 | 1.000 | 3 | GO:0042382 | CC | paraspeckles |
| 676 | red | 542 | 8.6e-04 | 1.000 | 4 | GO:0071732 | BP | cellular response to nitric oxide |
| 677 | red | 542 | 8.7e-04 | 1.000 | 9 | GO:0032204 | BP | regulation of telomere maintenance |
| 678 | red | 542 | 1.2e-03 | 1.000 | 4 | GO:0036035 | BP | osteoclast development |
| 679 | red | 542 | 1.2e-03 | 1.000 | 12 | GO:0045335 | CC | phagocytic vesicle |
| 680 | red | 542 | 1.3e-03 | 1.000 | 2 | GO:0007521 | BP | muscle cell fate determination |
| 681 | royalblue | 152 | 1.9e-05 | 0.340 | 3 | GO:0006689 | BP | ganglioside catabolic process |
| 682 | royalblue | 152 | 9.7e-05 | 1.000 | 2 | GO:0004563 | MF | beta-N-acetylhexosaminidase activity |
| 683 | royalblue | 152 | 1.5e-04 | 1.000 | 3 | GO:0030914 | CC | STAGA complex |
| 684 | royalblue | 152 | 2.5e-04 | 1.000 | 3 | GO:0046479 | BP | glycosphingolipid catabolic process |
| 685 | royalblue | 152 | 4.0e-04 | 1.000 | 3 | GO:0019377 | BP | glycolipid catabolic process |
| 686 | royalblue | 152 | 4.7e-04 | 1.000 | 11 | GO:0018205 | BP | peptidyl-lysine modification |
| 687 | royalblue | 152 | 5.8e-04 | 1.000 | 3 | GO:0005685 | CC | U1 snRNP |
| 688 | royalblue | 152 | 6.9e-04 | 1.000 | 3 | GO:0001573 | BP | ganglioside metabolic process |
| 689 | royalblue | 152 | 8.2e-04 | 1.000 | 3 | GO:0046514 | BP | ceramide catabolic process |
| 690 | royalblue | 152 | 9.5e-04 | 1.000 | 2 | GO:0061734 | BP | parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization |
| 691 | saddlebrown | 96 | 6.8e-04 | 1.000 | 3 | GO:0035872 | BP | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| 692 | saddlebrown | 96 | 6.8e-04 | 1.000 | 3 | GO:0070423 | BP | nucleotide-binding oligomerization domain containing signaling pathway |
| 693 | saddlebrown | 96 | 7.6e-04 | 1.000 | 4 | GO:0003777 | MF | microtubule motor activity |
| 694 | saddlebrown | 96 | 1.1e-03 | 1.000 | 2 | GO:0070431 | BP | nucleotide-binding oligomerization domain containing 2 signaling pathway |
| 695 | saddlebrown | 96 | 1.8e-03 | 1.000 | 2 | GO:0014067 | BP | negative regulation of phosphatidylinositol 3-kinase signaling |
| 696 | saddlebrown | 96 | 2.6e-03 | 1.000 | 2 | GO:0008569 | MF | ATP-dependent microtubule motor activity, minus-end-directed |
| 697 | saddlebrown | 96 | 3.7e-03 | 1.000 | 4 | GO:0031929 | BP | TOR signaling |
| 698 | saddlebrown | 96 | 3.8e-03 | 1.000 | 3 | GO:0002753 | BP | cytoplasmic pattern recognition receptor signaling pathway |
| 699 | saddlebrown | 96 | 4.1e-03 | 1.000 | 4 | GO:0051225 | BP | spindle assembly |
| 700 | saddlebrown | 96 | 4.8e-03 | 1.000 | 4 | GO:0003774 | MF | motor activity |
| 701 | salmon | 245 | 1.6e-03 | 1.000 | 2 | GO:1990769 | CC | proximal neuron projection |
| 702 | salmon | 245 | 2.6e-03 | 1.000 | 3 | GO:0004659 | MF | prenyltransferase activity |
| 703 | salmon | 245 | 2.6e-03 | 1.000 | 2 | GO:0030222 | BP | eosinophil differentiation |
| 704 | salmon | 245 | 2.6e-03 | 1.000 | 2 | GO:0098821 | MF | BMP receptor activity |
| 705 | salmon | 245 | 2.9e-03 | 1.000 | 5 | GO:0050771 | BP | negative regulation of axonogenesis |
| 706 | salmon | 245 | 3.9e-03 | 1.000 | 2 | GO:0007172 | BP | signal complex assembly |
| 707 | salmon | 245 | 4.1e-03 | 1.000 | 5 | GO:0070491 | MF | repressing transcription factor binding |
| 708 | salmon | 245 | 4.1e-03 | 1.000 | 3 | GO:0007398 | BP | ectoderm development |
| 709 | salmon | 245 | 4.2e-03 | 1.000 | 4 | GO:0045540 | BP | regulation of cholesterol biosynthetic process |
| 710 | salmon | 245 | 4.8e-03 | 1.000 | 3 | GO:0030552 | MF | cAMP binding |
| 711 | salmon2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0006429 | BP | leucyl-tRNA aminoacylation |
| 712 | salmon2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0032223 | BP | negative regulation of synaptic transmission, cholinergic |
| 713 | salmon2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0045212 | BP | neurotransmitter receptor biosynthetic process |
| 714 | salmon2 | 31 | 2.1e-03 | 1.000 | 1 | GO:1903093 | BP | regulation of protein K48-linked deubiquitination |
| 715 | salmon2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0099629 | CC | postsynaptic specialization of symmetric synapse |
| 716 | salmon2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0004823 | MF | leucine-tRNA ligase activity |
| 717 | salmon2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0005471 | MF | ATP:ADP antiporter activity |
| 718 | salmon2 | 31 | 3.7e-03 | 1.000 | 2 | GO:0004879 | MF | nuclear receptor activity |
| 719 | salmon2 | 31 | 3.7e-03 | 1.000 | 2 | GO:0098531 | MF | ligand-activated transcription factor activity |
| 720 | salmon2 | 31 | 4.1e-03 | 1.000 | 1 | GO:0001507 | BP | acetylcholine catabolic process in synaptic cleft |
| 721 | salmon4 | 54 | 4.7e-04 | 1.000 | 2 | GO:0042182 | BP | ketone catabolic process |
| 722 | salmon4 | 54 | 1.0e-03 | 1.000 | 2 | GO:0070207 | BP | protein homotrimerization |
| 723 | salmon4 | 54 | 1.2e-03 | 1.000 | 2 | GO:0000963 | BP | mitochondrial RNA processing |
| 724 | salmon4 | 54 | 1.2e-03 | 1.000 | 2 | GO:1990023 | CC | mitotic spindle midzone |
| 725 | salmon4 | 54 | 1.3e-03 | 1.000 | 2 | GO:0070206 | BP | protein trimerization |
| 726 | salmon4 | 54 | 2.7e-03 | 1.000 | 2 | GO:0043032 | BP | positive regulation of macrophage activation |
| 727 | salmon4 | 54 | 3.7e-03 | 1.000 | 1 | GO:0003285 | BP | septum secundum development |
| 728 | salmon4 | 54 | 3.7e-03 | 1.000 | 1 | GO:0003290 | BP | atrial septum secundum morphogenesis |
| 729 | salmon4 | 54 | 3.7e-03 | 1.000 | 1 | GO:0007225 | BP | patched ligand maturation |
| 730 | salmon4 | 54 | 3.7e-03 | 1.000 | 1 | GO:0007495 | BP | visceral mesoderm-endoderm interaction involved in midgut development |
| 731 | sienna3 | 83 | 1.4e-04 | 1.000 | 3 | GO:0010560 | BP | positive regulation of glycoprotein biosynthetic process |
| 732 | sienna3 | 83 | 1.9e-04 | 1.000 | 3 | GO:1903020 | BP | positive regulation of glycoprotein metabolic process |
| 733 | sienna3 | 83 | 8.0e-04 | 1.000 | 3 | GO:0010559 | BP | regulation of glycoprotein biosynthetic process |
| 734 | sienna3 | 83 | 8.8e-04 | 1.000 | 3 | GO:0019432 | BP | triglyceride biosynthetic process |
| 735 | sienna3 | 83 | 1.0e-03 | 1.000 | 2 | GO:0060050 | BP | positive regulation of protein glycosylation |
| 736 | sienna3 | 83 | 1.0e-03 | 1.000 | 13 | GO:0044255 | BP | cellular lipid metabolic process |
| 737 | sienna3 | 83 | 1.1e-03 | 1.000 | 16 | GO:0005739 | CC | mitochondrion |
| 738 | sienna3 | 83 | 1.3e-03 | 1.000 | 2 | GO:0043560 | MF | insulin receptor substrate binding |
| 739 | sienna3 | 83 | 1.4e-03 | 1.000 | 4 | GO:0006641 | BP | triglyceride metabolic process |
| 740 | sienna3 | 83 | 1.5e-03 | 1.000 | 15 | GO:0006629 | BP | lipid metabolic process |
| 741 | skyblue | 92 | 3.2e-05 | 0.600 | 13 | GO:0030036 | BP | actin cytoskeleton organization |
| 742 | skyblue | 92 | 4.8e-05 | 0.880 | 10 | GO:0007015 | BP | actin filament organization |
| 743 | skyblue | 92 | 6.7e-05 | 1.000 | 5 | GO:0097061 | BP | dendritic spine organization |
| 744 | skyblue | 92 | 1.1e-04 | 1.000 | 5 | GO:0106027 | BP | neuron projection organization |
| 745 | skyblue | 92 | 1.2e-04 | 1.000 | 13 | GO:0030029 | BP | actin filament-based process |
| 746 | skyblue | 92 | 1.3e-04 | 1.000 | 3 | GO:0097062 | BP | dendritic spine maintenance |
| 747 | skyblue | 92 | 1.6e-04 | 1.000 | 12 | GO:0097435 | BP | supramolecular fiber organization |
| 748 | skyblue | 92 | 1.6e-04 | 1.000 | 6 | GO:0099173 | BP | postsynapse organization |
| 749 | skyblue | 92 | 1.8e-04 | 1.000 | 5 | GO:0099175 | BP | regulation of postsynapse organization |
| 750 | skyblue | 92 | 3.4e-04 | 1.000 | 3 | GO:0051497 | BP | negative regulation of stress fiber assembly |
| 751 | skyblue1 | 50 | 1.4e-03 | 1.000 | 2 | GO:0051571 | BP | positive regulation of histone H3-K4 methylation |
| 752 | skyblue1 | 50 | 1.9e-03 | 1.000 | 2 | GO:0043984 | BP | histone H4-K16 acetylation |
| 753 | skyblue1 | 50 | 3.0e-03 | 1.000 | 2 | GO:0051569 | BP | regulation of histone H3-K4 methylation |
| 754 | skyblue1 | 50 | 3.3e-03 | 1.000 | 1 | GO:1905025 | BP | negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential |
| 755 | skyblue1 | 50 | 3.3e-03 | 1.000 | 1 | GO:1905032 | BP | negative regulation of membrane repolarization during cardiac muscle cell action potential |
| 756 | skyblue1 | 50 | 3.3e-03 | 1.000 | 1 | GO:1990654 | BP | sebum secreting cell proliferation |
| 757 | skyblue1 | 50 | 3.3e-03 | 1.000 | 1 | GO:2001040 | BP | positive regulation of cellular response to drug |
| 758 | skyblue1 | 50 | 3.3e-03 | 1.000 | 1 | GO:0070975 | MF | FHA domain binding |
| 759 | skyblue1 | 50 | 3.4e-03 | 1.000 | 3 | GO:0034968 | BP | histone lysine methylation |
| 760 | skyblue1 | 50 | 4.1e-03 | 1.000 | 3 | GO:0018022 | BP | peptidyl-lysine methylation |
| 761 | skyblue2 | 53 | 8.9e-04 | 1.000 | 2 | GO:0003184 | BP | pulmonary valve morphogenesis |
| 762 | skyblue2 | 53 | 1.5e-03 | 1.000 | 2 | GO:0003177 | BP | pulmonary valve development |
| 763 | skyblue2 | 53 | 1.5e-03 | 1.000 | 2 | GO:0060065 | BP | uterus development |
| 764 | skyblue2 | 53 | 1.5e-03 | 1.000 | 2 | GO:0004707 | MF | MAP kinase activity |
| 765 | skyblue2 | 53 | 3.5e-03 | 1.000 | 1 | GO:0019310 | BP | inositol catabolic process |
| 766 | skyblue2 | 53 | 3.5e-03 | 1.000 | 1 | GO:0045225 | BP | negative regulation of CD4 production |
| 767 | skyblue2 | 53 | 3.5e-03 | 1.000 | 1 | GO:0048561 | BP | establishment of animal organ orientation |
| 768 | skyblue2 | 53 | 3.5e-03 | 1.000 | 1 | GO:0061143 | BP | alveolar primary septum development |
| 769 | skyblue2 | 53 | 3.5e-03 | 1.000 | 1 | GO:0071939 | BP | vitamin A import |
| 770 | skyblue2 | 53 | 3.5e-03 | 1.000 | 1 | GO:0090301 | BP | negative regulation of neural crest formation |
| 771 | skyblue3 | 81 | 1.6e-04 | 1.000 | 3 | GO:1902254 | BP | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| 772 | skyblue3 | 81 | 1.6e-04 | 1.000 | 3 | GO:0019865 | MF | immunoglobulin binding |
| 773 | skyblue3 | 81 | 3.2e-04 | 1.000 | 3 | GO:1902253 | BP | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| 774 | skyblue3 | 81 | 4.0e-04 | 1.000 | 3 | GO:1901797 | BP | negative regulation of signal transduction by p53 class mediator |
| 775 | skyblue3 | 81 | 4.3e-04 | 1.000 | 2 | GO:0060124 | BP | positive regulation of growth hormone secretion |
| 776 | skyblue3 | 81 | 1.2e-03 | 1.000 | 4 | GO:2001243 | BP | negative regulation of intrinsic apoptotic signaling pathway |
| 777 | skyblue3 | 81 | 1.3e-03 | 1.000 | 2 | GO:0048245 | BP | eosinophil chemotaxis |
| 778 | skyblue3 | 81 | 1.3e-03 | 1.000 | 2 | GO:0060123 | BP | regulation of growth hormone secretion |
| 779 | skyblue3 | 81 | 1.3e-03 | 1.000 | 28 | GO:0098772 | MF | molecular function regulator |
| 780 | skyblue3 | 81 | 1.3e-03 | 1.000 | 5 | GO:0018394 | BP | peptidyl-lysine acetylation |
| 781 | steelblue | 91 | 3.6e-05 | 0.660 | 2 | GO:0000448 | BP | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| 782 | steelblue | 91 | 3.4e-04 | 1.000 | 3 | GO:0000466 | BP | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| 783 | steelblue | 91 | 4.4e-04 | 1.000 | 3 | GO:0000469 | BP | cleavage involved in rRNA processing |
| 784 | steelblue | 91 | 5.3e-04 | 1.000 | 2 | GO:0006924 | BP | activation-induced cell death of T cells |
| 785 | steelblue | 91 | 9.2e-04 | 1.000 | 3 | GO:0000460 | BP | maturation of 5.8S rRNA |
| 786 | steelblue | 91 | 9.8e-04 | 1.000 | 2 | GO:0015379 | MF | potassium:chloride symporter activity |
| 787 | steelblue | 91 | 1.0e-03 | 1.000 | 6 | GO:0015291 | MF | secondary active transmembrane transporter activity |
| 788 | steelblue | 91 | 1.3e-03 | 1.000 | 2 | GO:0071340 | BP | skeletal muscle acetylcholine-gated channel clustering |
| 789 | steelblue | 91 | 2.3e-03 | 1.000 | 2 | GO:0055064 | BP | chloride ion homeostasis |
| 790 | steelblue | 91 | 2.3e-03 | 1.000 | 9 | GO:0007610 | BP | behavior |
| 791 | tan | 259 | 1.9e-06 | 0.034 | 10 | GO:0034446 | BP | substrate adhesion-dependent cell spreading |
| 792 | tan | 259 | 7.0e-05 | 1.000 | 6 | GO:1900024 | BP | regulation of substrate adhesion-dependent cell spreading |
| 793 | tan | 259 | 1.4e-04 | 1.000 | 4 | GO:0031290 | BP | retinal ganglion cell axon guidance |
| 794 | tan | 259 | 1.4e-04 | 1.000 | 4 | GO:0003756 | MF | protein disulfide isomerase activity |
| 795 | tan | 259 | 2.2e-04 | 1.000 | 4 | GO:0030277 | BP | maintenance of gastrointestinal epithelium |
| 796 | tan | 259 | 3.7e-04 | 1.000 | 6 | GO:0010812 | BP | negative regulation of cell-substrate adhesion |
| 797 | tan | 259 | 3.7e-04 | 1.000 | 16 | GO:0001667 | BP | ameboidal-type cell migration |
| 798 | tan | 259 | 4.4e-04 | 1.000 | 13 | GO:0010631 | BP | epithelial cell migration |
| 799 | tan | 259 | 4.9e-04 | 1.000 | 13 | GO:0090132 | BP | epithelium migration |
| 800 | tan | 259 | 6.1e-04 | 1.000 | 4 | GO:0010669 | BP | epithelial structure maintenance |
| 801 | thistle | 34 | 1.6e-03 | 1.000 | 2 | GO:0006891 | BP | intra-Golgi vesicle-mediated transport |
| 802 | thistle | 34 | 1.6e-03 | 1.000 | 3 | GO:0033135 | BP | regulation of peptidyl-serine phosphorylation |
| 803 | thistle | 34 | 2.2e-03 | 1.000 | 9 | GO:0005794 | CC | Golgi apparatus |
| 804 | thistle | 34 | 2.3e-03 | 1.000 | 1 | GO:0019265 | BP | glycine biosynthetic process, by transamination of glyoxylate |
| 805 | thistle | 34 | 2.3e-03 | 1.000 | 1 | GO:0019481 | BP | L-alanine catabolic process, by transamination |
| 806 | thistle | 34 | 2.3e-03 | 1.000 | 1 | GO:0031161 | BP | phosphatidylinositol catabolic process |
| 807 | thistle | 34 | 2.3e-03 | 1.000 | 1 | GO:1903060 | BP | negative regulation of protein lipidation |
| 808 | thistle | 34 | 2.3e-03 | 1.000 | 1 | GO:1904120 | BP | positive regulation of otic vesicle morphogenesis |
| 809 | thistle | 34 | 2.3e-03 | 1.000 | 1 | GO:0043160 | CC | acrosomal lumen |
| 810 | thistle | 34 | 2.3e-03 | 1.000 | 1 | GO:0008453 | MF | alanine-glyoxylate transaminase activity |
| 811 | thistle1 | 59 | 4.1e-04 | 1.000 | 3 | GO:0003954 | MF | NADH dehydrogenase activity |
| 812 | thistle1 | 59 | 4.1e-04 | 1.000 | 3 | GO:0008137 | MF | NADH dehydrogenase (ubiquinone) activity |
| 813 | thistle1 | 59 | 4.2e-04 | 1.000 | 2 | GO:0072386 | BP | plus-end-directed organelle transport along microtubule |
| 814 | thistle1 | 59 | 4.5e-04 | 1.000 | 3 | GO:0005747 | CC | mitochondrial respiratory chain complex I |
| 815 | thistle1 | 59 | 4.5e-04 | 1.000 | 3 | GO:0030964 | CC | NADH dehydrogenase complex |
| 816 | thistle1 | 59 | 4.5e-04 | 1.000 | 3 | GO:0045271 | CC | respiratory chain complex I |
| 817 | thistle1 | 59 | 4.5e-04 | 1.000 | 4 | GO:1990204 | CC | oxidoreductase complex |
| 818 | thistle1 | 59 | 6.0e-04 | 1.000 | 3 | GO:0006120 | BP | mitochondrial electron transport, NADH to ubiquinone |
| 819 | thistle1 | 59 | 9.8e-04 | 1.000 | 2 | GO:0030673 | CC | axolemma |
| 820 | thistle1 | 59 | 1.1e-03 | 1.000 | 3 | GO:0016655 | MF | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
| 821 | thistle2 | 63 | 1.1e-03 | 1.000 | 2 | GO:0000727 | BP | double-strand break repair via break-induced replication |
| 822 | thistle2 | 63 | 2.5e-03 | 1.000 | 2 | GO:0048025 | BP | negative regulation of mRNA splicing, via spliceosome |
| 823 | thistle2 | 63 | 2.8e-03 | 1.000 | 2 | GO:0006379 | BP | mRNA cleavage |
| 824 | thistle2 | 63 | 2.8e-03 | 1.000 | 2 | GO:0004812 | MF | aminoacyl-tRNA ligase activity |
| 825 | thistle2 | 63 | 3.0e-03 | 1.000 | 4 | GO:0006399 | BP | tRNA metabolic process |
| 826 | thistle2 | 63 | 3.1e-03 | 1.000 | 2 | GO:0033119 | BP | negative regulation of RNA splicing |
| 827 | thistle2 | 63 | 3.3e-03 | 1.000 | 3 | GO:0008589 | BP | regulation of smoothened signaling pathway |
| 828 | thistle2 | 63 | 3.3e-03 | 1.000 | 3 | GO:1901992 | BP | positive regulation of mitotic cell cycle phase transition |
| 829 | thistle2 | 63 | 4.1e-03 | 1.000 | 2 | GO:0006418 | BP | tRNA aminoacylation for protein translation |
| 830 | thistle2 | 63 | 4.2e-03 | 1.000 | 1 | GO:0006427 | BP | histidyl-tRNA aminoacylation |
| 831 | thistle3 | 33 | 1.8e-04 | 1.000 | 2 | GO:0071281 | BP | cellular response to iron ion |
| 832 | thistle3 | 33 | 2.5e-04 | 1.000 | 6 | GO:0043025 | CC | neuronal cell body |
| 833 | thistle3 | 33 | 5.0e-04 | 1.000 | 6 | GO:0044297 | CC | cell body |
| 834 | thistle3 | 33 | 5.2e-04 | 1.000 | 2 | GO:0060391 | BP | positive regulation of SMAD protein signal transduction |
| 835 | thistle3 | 33 | 6.0e-04 | 1.000 | 2 | GO:0098780 | BP | response to mitochondrial depolarisation |
| 836 | thistle3 | 33 | 7.4e-04 | 1.000 | 6 | GO:0043043 | BP | peptide biosynthetic process |
| 837 | thistle3 | 33 | 7.6e-04 | 1.000 | 2 | GO:0010667 | BP | negative regulation of cardiac muscle cell apoptotic process |
| 838 | thistle3 | 33 | 9.4e-04 | 1.000 | 2 | GO:0000423 | BP | mitophagy |
| 839 | thistle3 | 33 | 1.0e-03 | 1.000 | 2 | GO:0010664 | BP | negative regulation of striated muscle cell apoptotic process |
| 840 | thistle3 | 33 | 1.0e-03 | 1.000 | 2 | GO:1901522 | BP | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| 841 | turquoise | 2713 | 2.1e-04 | 1.000 | 6 | GO:0070471 | BP | uterine smooth muscle contraction |
| 842 | turquoise | 2713 | 8.1e-04 | 1.000 | 13 | GO:0030261 | BP | chromosome condensation |
| 843 | turquoise | 2713 | 8.1e-04 | 1.000 | 13 | GO:0008200 | MF | ion channel inhibitor activity |
| 844 | turquoise | 2713 | 9.8e-04 | 1.000 | 5 | GO:0070472 | BP | regulation of uterine smooth muscle contraction |
| 845 | turquoise | 2713 | 1.1e-03 | 1.000 | 4 | GO:1903142 | BP | positive regulation of establishment of endothelial barrier |
| 846 | turquoise | 2713 | 1.1e-03 | 1.000 | 4 | GO:1903850 | BP | regulation of cristae formation |
| 847 | turquoise | 2713 | 1.2e-03 | 1.000 | 13 | GO:0016248 | MF | channel inhibitor activity |
| 848 | turquoise | 2713 | 1.4e-03 | 1.000 | 46 | GO:0060348 | BP | bone development |
| 849 | turquoise | 2713 | 1.8e-03 | 1.000 | 6 | GO:0005247 | MF | voltage-gated chloride channel activity |
| 850 | turquoise | 2713 | 1.9e-03 | 1.000 | 175 | GO:0005768 | CC | endosome |
| 851 | violet | 90 | 1.7e-05 | 0.320 | 4 | GO:0021799 | BP | cerebral cortex radially oriented cell migration |
| 852 | violet | 90 | 5.8e-05 | 1.000 | 4 | GO:0021795 | BP | cerebral cortex cell migration |
| 853 | violet | 90 | 1.7e-04 | 1.000 | 4 | GO:0022029 | BP | telencephalon cell migration |
| 854 | violet | 90 | 1.9e-04 | 1.000 | 4 | GO:0021885 | BP | forebrain cell migration |
| 855 | violet | 90 | 2.3e-04 | 1.000 | 3 | GO:0021801 | BP | cerebral cortex radial glia guided migration |
| 856 | violet | 90 | 3.6e-04 | 1.000 | 2 | GO:2000697 | BP | negative regulation of epithelial cell differentiation involved in kidney development |
| 857 | violet | 90 | 5.1e-04 | 1.000 | 3 | GO:0034383 | BP | low-density lipoprotein particle clearance |
| 858 | violet | 90 | 1.0e-03 | 1.000 | 2 | GO:0005381 | MF | iron ion transmembrane transporter activity |
| 859 | violet | 90 | 1.0e-03 | 1.000 | 3 | GO:1901186 | BP | positive regulation of ERBB signaling pathway |
| 860 | violet | 90 | 1.4e-03 | 1.000 | 4 | GO:1901184 | BP | regulation of ERBB signaling pathway |
| 861 | white | 101 | 2.7e-04 | 1.000 | 2 | GO:0048808 | BP | male genitalia morphogenesis |
| 862 | white | 101 | 7.9e-04 | 1.000 | 3 | GO:0010453 | BP | regulation of cell fate commitment |
| 863 | white | 101 | 9.4e-04 | 1.000 | 2 | GO:0033327 | BP | Leydig cell differentiation |
| 864 | white | 101 | 1.7e-03 | 1.000 | 3 | GO:0051898 | BP | negative regulation of protein kinase B signaling |
| 865 | white | 101 | 1.9e-03 | 1.000 | 5 | GO:0016331 | BP | morphogenesis of embryonic epithelium |
| 866 | white | 101 | 2.0e-03 | 1.000 | 2 | GO:0060513 | BP | prostatic bud formation |
| 867 | white | 101 | 3.4e-03 | 1.000 | 2 | GO:0042659 | BP | regulation of cell fate specification |
| 868 | white | 101 | 3.4e-03 | 1.000 | 2 | GO:0060601 | BP | lateral sprouting from an epithelium |
| 869 | white | 101 | 3.9e-03 | 1.000 | 2 | GO:0035112 | BP | genitalia morphogenesis |
| 870 | white | 101 | 4.2e-03 | 1.000 | 3 | GO:0001099 | MF | basal RNA polymerase II transcription machinery binding |
| 871 | yellow | 644 | 3.1e-04 | 1.000 | 3 | GO:0032057 | BP | negative regulation of translational initiation in response to stress |
| 872 | yellow | 644 | 7.4e-04 | 1.000 | 3 | GO:0036492 | BP | eiF2alpha phosphorylation in response to endoplasmic reticulum stress |
| 873 | yellow | 644 | 7.8e-04 | 1.000 | 5 | GO:0043555 | BP | regulation of translation in response to stress |
| 874 | yellow | 644 | 1.0e-03 | 1.000 | 5 | GO:0036499 | BP | PERK-mediated unfolded protein response |
| 875 | yellow | 644 | 1.4e-03 | 1.000 | 3 | GO:0032055 | BP | negative regulation of translation in response to stress |
| 876 | yellow | 644 | 1.8e-03 | 1.000 | 2 | GO:1901074 | BP | regulation of engulfment of apoptotic cell |
| 877 | yellow | 644 | 1.8e-03 | 1.000 | 2 | GO:1901076 | BP | positive regulation of engulfment of apoptotic cell |
| 878 | yellow | 644 | 1.8e-03 | 1.000 | 2 | GO:1990116 | BP | ribosome-associated ubiquitin-dependent protein catabolic process |
| 879 | yellow | 644 | 1.8e-03 | 1.000 | 2 | GO:1990441 | BP | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress |
| 880 | yellow | 644 | 1.8e-03 | 1.000 | 2 | GO:2000676 | BP | positive regulation of type B pancreatic cell apoptotic process |
| 881 | yellow4 | 46 | 3.8e-05 | 0.700 | 6 | GO:0045926 | BP | negative regulation of growth |
| 882 | yellow4 | 46 | 5.2e-05 | 0.950 | 2 | GO:0030274 | MF | LIM domain binding |
| 883 | yellow4 | 46 | 1.8e-04 | 1.000 | 8 | GO:0040008 | BP | regulation of growth |
| 884 | yellow4 | 46 | 6.4e-04 | 1.000 | 3 | GO:0060170 | CC | ciliary membrane |
| 885 | yellow4 | 46 | 6.6e-04 | 1.000 | 2 | GO:0006000 | BP | fructose metabolic process |
| 886 | yellow4 | 46 | 1.2e-03 | 1.000 | 4 | GO:0030308 | BP | negative regulation of cell growth |
| 887 | yellow4 | 46 | 1.2e-03 | 1.000 | 5 | GO:0048638 | BP | regulation of developmental growth |
| 888 | yellow4 | 46 | 1.3e-03 | 1.000 | 2 | GO:0031643 | BP | positive regulation of myelination |
| 889 | yellow4 | 46 | 1.6e-03 | 1.000 | 2 | GO:0048714 | BP | positive regulation of oligodendrocyte differentiation |
| 890 | yellow4 | 46 | 2.3e-03 | 1.000 | 4 | GO:0051259 | BP | protein complex oligomerization |
| 891 | yellowgreen | 86 | 5.9e-04 | 1.000 | 11 | GO:0007169 | BP | transmembrane receptor protein tyrosine kinase signaling pathway |
| 892 | yellowgreen | 86 | 7.3e-04 | 1.000 | 3 | GO:0043276 | BP | anoikis |
| 893 | yellowgreen | 86 | 9.6e-04 | 1.000 | 3 | GO:0070317 | BP | negative regulation of G0 to G1 transition |
| 894 | yellowgreen | 86 | 1.2e-03 | 1.000 | 3 | GO:0045023 | BP | G0 to G1 transition |
| 895 | yellowgreen | 86 | 1.4e-03 | 1.000 | 2 | GO:0033197 | BP | response to vitamin E |
| 896 | yellowgreen | 86 | 2.1e-03 | 1.000 | 2 | GO:0009143 | BP | nucleoside triphosphate catabolic process |
| 897 | yellowgreen | 86 | 2.4e-03 | 1.000 | 2 | GO:0071437 | CC | invadopodium |
| 898 | yellowgreen | 86 | 2.8e-03 | 1.000 | 2 | GO:0010715 | BP | regulation of extracellular matrix disassembly |
| 899 | yellowgreen | 86 | 2.8e-03 | 1.000 | 2 | GO:0033631 | BP | cell-cell adhesion mediated by integrin |
| 900 | yellowgreen | 86 | 3.7e-03 | 1.000 | 2 | GO:0034505 | BP | tooth mineralization |
Xarxa cytoscape
Factors de transcripció tots els mòduls associats
Factors de transcripció mòduls per separat
NA
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | geneSet | predrem__nrMotif1941 | 4.45 | 0.0846 | NA | 16 | 746 | BSX;DDR1;EPM2A;ETV1;MEOX2;MTRNR2L10;NCOA1;NOS3;PAPPA2;PFKFB3;RAB38;SV2A;TFDP2;THOC1;VPS37C;ZNF286A | ||
| 2 | geneSet | hdpi__POLE3 | 4.26 | 0.0823 | POLE3 (directAnnotation). | NA | 22 | 1757 | CACNA1A;CCDC42;DDR1;GK;GPC6;GRM2;HCK;IP6K3;LAMC1;NCOA1;NOS3;OR52B6;OR5B17;PAPPA2;PFKFB3;PRDM10;RNF112;SEMA6B;SV2A;TNFAIP2;VPS37C;WNT3 | |
| 3 | geneSet | cisbp__M6356 | 4.25 | 0.0821 | MZF1 (directAnnotation). | NA | 15 | 796 | CACNA1A;ENO2;ETV1;HR;HS3ST3B1;IP6K3;NEUROG1;NOS3;SDC4;SV2A;TNFAIP2;TNXB;WNT3;ZDHHC5;ZFP36L1 | |
| 4 | geneSet | neph__UW.Motif.0566 | 4.20 | 0.0815 | NA | 10 | 319 | ANKFN1;ETV1;LHCGR;MEOX2;NOS3;PAPPA2;PFKFB3;TFEB;VPS37C;ZFP36L1 | ||
| 5 | geneSet | transfac_pro__M06068 | 4.00 | 0.0791 | ZNF716 (directAnnotation). | NA | 13 | 746 | CACNA1A;DDR1;EPM2A;GPC6;HCK;IP6K3;PAPPA2;PDIA3;PRDM10;SDC4;TFEB;TNXB;ZNF652 | |
| 6 | geneSet | predrem__nrMotif2541 | 3.89 | 0.0777 | NA | 23 | 1924 | BSX;C10orf128;CDC25A;CLEC9A;DDR1;EPM2A;EPT1;ETV1;IP6K3;KRT74;NCOA1;OR5AU1;OR5B17;PAPPA2;PRDM10;RPS26;SDC4;SV2A;TFDP2;TFEB;TNXB;VPS37C;ZNF652 | ||
| 7 | geneSet | taipale_tf_pairs__GCM2_PITX1_RTRCGGGSGATTAN_CAP_repr | 3.85 | 0.0772 | GCM2; PITX1 (directAnnotation). | NA | 23 | 1992 | ANKFN1;CDC25A;CYB5A;EPM2A;EPT1;ETV1;HCK;HR;IP6K3;KRT74;LAMC1;LAPTM4A;NCOA1;NEUROG1;OR5AU1;PAPPA2;PRDM10;SCAP;SDC4;SV2A;TFDP2;TFEB;ZDHHC5 | |
| 8 | geneSet | predrem__nrMotif88 | 3.80 | 0.0766 | NA | 11 | 481 | CNP;ETV1;NEUROG1;PAPPA2;PRDM10;SDC4;TFDP2;TNXB;WNT3;YME1L1;ZFP36L1 | ||
| 9 | geneSet | jaspar__MA1096.1 | 3.76 | 0.0761 | NA | 9 | 341 | ANKFN1;DGCR2;EPT1;GPR119;HS3ST3B1;MEOX2;PAPPA2;TFEB;TNFAIP2 | ||
| 10 | geneSet | hocomoco__PRD14_HUMAN.H11MO.0.A | 3.76 | 0.0760 | PRDM14 (directAnnotation). | NA | 15 | 804 | ANKFN1;ARMC3;C10orf128;EPM2A;GPC6;HCK;KRT74;LAMC1;NOS3;PRDM10;RAB38;SV2A;WNT3;ZFP36L1;ZNF652 |